Baseline risk factors associated with all-cause early hospitalization of older patients following admission to Danish municipal temporary stays | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Baseline risk factors associated with all-cause early hospitalization of older patients following admission to Danish municipal temporary stays Mahan Rajaeigolsefidi, Anton Pottegård, Kasper Edwards, Kathrin Kirchner This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7740773/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 13 Jan, 2026 Read the published version in BMC Health Services Research → Version 1 posted 10 You are reading this latest preprint version Abstract Background Transitions from hospital to community are high-risk for older adults. In Denmark, municipal temporary stay (TS) facilities provide short-term, bed-based post-acute support, but determinants of early (re)hospitalization after TS admission are not well described. We estimated baseline risk factors for 30-day and 180-day hospitalization among TS patients. Methods We performed a register-based cohort study that includes adults with TS admission in 14 municipalities (2016–2023). Individual-level linkages captured demographics, diagnosis history, healthcare-utilization markers, and characteristics of recent hospitalization episodes. Outcomes were all-cause hospitalization within 30 and 180 days after the index TS admission, with death treated as a competing event. We estimated cumulative incidence using the Aalen-Johansen method and fitted additive competing-risk regression with inverse failure probability weighting to obtain absolute risk ratios (ARRs). Discrimination for 30-day risk was assessed with time-dependent c-index and Brier score using 3-fold cross-validation. Results Among 11,284 patients (median age 81 years), 26.1% were hospitalized, and 7.6% died within 30 days without prior hospitalization. In adjusted models, male sex (ARR 1.16, 95% CI 1.09–1.24), higher multimorbidity (1–2 vs 0: 1.17, 1.04–1.31; ≥3 vs 0: 1.43, 1.27–1.61), and recent hospitalization (1.24, 1.14–1.34) increased 30-day risk, whereas older age decreased it per 10 years (0.96, 0.93–0.98). Several morbidities were associated with higher 30-day risk (cancer-related morbidities, cirrhosis, chronic kidney disease, chronic heart failure, atrial fibrillation, chronic pulmonary disease, diabetes), while dementia and prior stroke/TIA were associated with lower risk. Healthcare-utilization markers showed dose-response relations (≥ 4 prior hospitalizations: 1.58; ≥10 medications: 1.28; ≥3 procedures: 1.34). In the recently hospitalized subgroup, a fall-injury primary diagnosis reduced 30-day risk (0.88), recent surgery increased it (1.09), and hospital stays > 14 days conferred higher risk (1.31). The best 30-day model yielded a c-index of 0.623 and Brier score of 0.186. Conclusions Early (re)hospitalization after TS admission is common and patterned by sex, multimorbidity, intensive prior healthcare use, and selected morbidities. Although model discrimination was modest, the identified risk factors can inform targeted interventions in transitional care delivered at TS settings. Trial registration Clinical trial number: not applicable. Transitional care Intermediate care Post-acute care Temporary stay Older adults Hospitalization Hospital readmission Risk regression Competing risks Denmark Figures Figure 1 Background Care transitions across healthcare settings are widely recognized as high-risk events, particularly for frail older patients [ 1 ]. Older adults often have complex health and social needs, and many experience complications leading to elevated adverse outcomes such as hospital readmissions [ 2 , 3 ]. In response, health systems worldwide have developed intermediate or transitional care services to support patients during the post-acute period and mitigate these risks. Such services are designed to ensure continuity and coordination of care as patients transfer from hospital to the community, aiming to improve outcomes and prevent avoidable (re)hospitalizations [ 4 – 6 ]. These intermediate care models, variously termed hospital-at-home, step-down units, community rehabilitation beds, or other names, provide short-term, restorative care at the interface between hospital and home [ 4 , 7 – 9 ]. In Denmark, municipal temporary stay (TS) facilities have been established across all 98 municipalities as an intermediate care solution for older patients who require short-term care that cannot be provided in their home. These facilities offer bed-based, 24-hour support typically after hospital discharge, though some patients are admitted directly from the community [ 10 – 13 ]. No centralized national guidelines for TS operations exist, and each municipality organizes its facilities independently. TS units are typically not required to have physicians on site, with medical responsibility falling to the patient’s general practitioner or the discharging hospital [ 12 ]. Despite the expansion of TSs as a key component of health care in Denmark, empirical research on TS patient populations has been limited until recently. Two recent studies have begun to shed light on this patient group using a large cohort of 11,424 TS patients [ 13 , 14 ]. The first study described medication use patterns [ 14 ], finding a median of 6 different drug classes used per patient, and that 68% of patients were on polypharmacy (≥ 5 drug classes) at admission. High-risk medications were common, and the rate of new drug initiations spiked sharply upon entry into TS facilities. A second study explored TS patients’ baseline characteristics and trajectories [ 13 ], revealing a heterogeneous profile of advanced age (median 81 years), high comorbidity burden, and substantial prior healthcare utilization. About 70% of TS admissions followed directly after a hospital discharge, and the remaining 30% were admitted from the community. Notably, intermediate care did not eliminate the need for acute hospital care: 7% of patients in the cohort were transferred to a hospital during their TS episode, typically within the first two weeks of their stay, and in total, about 20% experienced a hospital admission within 30 days after discharge from TS. Although the baseline risk factors for 30-day mortality were analyzed, the study did not investigate the correlates of hospital admissions. Health services research consistently uses readmission rates as an indicator of care quality and transition success [ 15 – 17 ]. Although studying risk factors of readmissions after hospital discharge has received noticeable attention internationally and in Denmark [ 18 – 22 ], risk factors of hospitalization in older adults admitted to intermediate and transitional care facilities are sparsely described [ 23 – 27 ]. Notably, we found no studies investigating hospitalization risk factors in Danish municipal TS patients. Due to the diverse and fragmented implementation of intermediate care structures worldwide and the potential differences in patient populations and care settings [ 4 ], analyzing adverse outcomes in each intermediate care structure is necessary to provide insights into key targets of future interventions. This study aims to identify baseline risk factors for 30-day and 180-day hospitalizations after admission to Danish municipal TS facilities. Methods Study design We performed an observational, register-based cohort study using routinely collected Danish health and administrative data. The analysis focused on adults with at least one TS admission between January 1, 2016, and December 31, 2023, in any of the 14 participating Danish municipalities (see supplementary material–Table A1 for a detailed list of municipalities). Data sources All records were linked at the individual level via the unique Central Person Register (CPR) number. Municipal TS records provided admission and discharge dates; the Civil Registration System supplied demographic characteristics (date of birth, sex) together with migration and death dates [ 28 ]; hospital contacts and ICD-10 discharge diagnoses were retrieved from the Danish National Patient Registry (DNPR) [ 29 ], and Health Care Classification System (SKS) procedure codes within the DNPR identified surgical interventions [ 30 , 31 ]; finally, information on dispensed prescriptions, coded according to the Anatomical Therapeutic Chemical (ATC) scheme, was obtained from the Danish National Prescription Registry [ 32 ]. All registries are nationwide, continuously updated, and regarded as virtually complete for the variables included. Assembly of the analytic cohort and follow-up The source population comprised 11,584 individuals with at least one TS episode falling entirely within the 2016–2023 window. We excluded 300 persons who had lived outside Denmark at any point during the five years preceding their first TS admission because their registry histories were potentially incomplete, leaving a final cohort of 11,284 patients. Patients with multiple stays contributed only their first episode. This approach yielded one observation per individual. The end of observation was April 4, 2024. Patients were followed prospectively until the first hospitalization episode or death after the index TS admission date, or until the end of observation, whichever came first. Variables The primary outcome variable of interest was all-cause hospitalization within 30 days after the index TS admission. However, to investigate longer-term associations and the potential differences in short-term versus longer-term trajectories, we also analyzed 180-day hospitalization and the associated risk factors. We included death as a competing outcome. Sex, as assigned at birth, and age at the time of index TS admission were included as demographic variables. A set of 27 morbidities was identified using the 5-year diagnosis history of inpatient hospital contacts. The ICD-10 mapping of morbidities is presented in supplementary material–Table A2. Multimorbidity was defined as the number of morbidities identified in each patient. Recent hospitalization, a binary variable, was defined as whether the patient had a hospitalization that ended within seven days prior to the index TS admission. Hospitalization burden, polypharmacy, and frequency of surgeries were calculated, respectively, as the number of hospitalizations, unique prescribed medications at the fourth ATC level, and surgical interventions within one year before the index TS admission. When identifying surgical procedures, we excluded specific SKS codes as presented in the supplementary material–Table A3. For patients with a recent hospitalization, we calculated three variables derived from their recent hospitalization episode. We identified fall injuries based on the primary diagnoses of recent hospitalizations using ICD-10 mapping of supplementary material–Table A4. We also determined whether a patient had undergone surgical interventions during a recent hospitalization. The length of stay of the recent hospitalization episode was also calculated. If a patient had more than one recent hospitalization per definition, we calculated the cumulative length of stay. Analytic process All calculations and analyses were performed using R version 4.4.3. We obtained cumulative incidence functions (CIFs) of hospitalization, considering death as a competing outcome, using the Aalen-Johansen method [ 33 ]. The Aalen-Johansen CIFs, stratified by sex, age group, multimorbidity level, and recent hospitalization, were plotted for the first 180 days after the index TS admission. We used the estimations of CIF to calculate median time-to-hospitalization, and via bootstrapping with 1000 resamples, we derived the 95% confidence intervals (CI). We employed the Kaplan-Meier method to calculate the median time-to-death, and the 95% CIs were constructed using the log-minus-log transformation method. These time-to-event estimates, together with counts and proportions of 30-day hospitalization and death, were reported stratified by sex, age group, multimorbidity level, recent hospitalization, and individual selected morbidities. Throughout the rest of the analysis, we assessed the association of different variables with short-term and longer-term future hospitalization, using the 30-day and 180-day absolute risk ratios (ARRs). ARRs were estimated using an additive absolute risk regression model developed by Scheike and Zhang [ 34 ]. This approach directly models absolute risk over time, rather than cause-specific hazards, allowing for intuitive interpretation of relative risks. The model accounts for competing risks and adjusts for confounding using inverse failure probability weighting (IFPW), which corrects for censoring by reweighting individuals according to the inverse probability of remaining uncensored [ 35 ]. The censoring distribution required for IFPW was estimated using the Kaplan-Meier method. Although patients were potentially followed beyond 30 or 180 days, follow-up data after each time window did not contribute to the respective estimated risks. The 95% CIs were derived from robust sandwich variance estimators, based on asymptotic distribution of the estimating equations [ 34 ]. When conducting risk regression, including all variables simultaneously would adjust for factors that are plausibly on the causal pathway, yielding controlled direct rather than total effects and risking overadjustment or collider bias. We therefore used a pre-specified block-wise strategy. The analysis of risk factors associated with hospitalization after TS admission was conducted in four steps. First, age, sex, multimorbidity, and recent hospitalization were evaluated using both univariate models and an adjusted model including all four variables. Second, the association of each morbidity with hospitalization was assessed adjusting for age, sex, and multimorbidity as the core baseline covariates. Morbidities for which we found significant 30-day ARRs (p < 0.05) were then added to the covariates list for future steps. Third, the association of healthcare utilization markers, including one-year history of hospitalization burden, polypharmacy, and frequency of surgery, was analyzed adjusting for the full set of covariates determined in previous steps. Finally, in the fourth step, we only included the subset of the cohort with a recent hospitalization prior to the index TS admission. Within this subset of patients, in addition to variables assessed in the third step, three new variables related to the recent hospitalization episodes, i.e., primary diagnoses of fall injury, surgical interventions, and length of stay at hospital, were analyzed. The models for each variable were adjusted for the complete set of covariates determined at the second step. Finally, to evaluate the discriminant ability of the identified risk factors for 30-day hospitalization, several combinations of significant variables were used for risk prediction (see supplementary material–Table A5). Time-dependent concordance (c-index) and Brier scores were calculated for each model using 3-fold cross-validation. Additionally, the discriminant performance of the risk regression method used in this study [ 34 ] was compared with the widely used Fine-Gray method. Results The study population had a median age of 81 years (interquartile range [IQR] 73–87). The baseline characteristics of the study population are reported in Table 1 . The median time-to-hospitalization of the cohort was 7 months (IQR 1–47). The median time-to-death was 24 months (IQR 4–60). Almost 26% of the patients were hospitalized within 30 days, and roughly 8% of the patients died within the same 30-day window without being hospitalized. Figure 1 illustrates the CIFs of hospitalization and death over 180 days. Male sex, younger age groups, higher multimorbidity burden, and recent hospitalization demonstrated higher probabilities of hospitalization over time. Figure 1. Stratified cumulative incidence functions (95% CI band) of hospitalization and the competing outcome of death. ## insert Fig. 1 here ## Table 1 Baseline characteristics of study population in terms of hospitalization and death outcomes. Median time-to-event, months (95% CI) Count (%) of 30-day outcomes N (%) Hospitalization Death Hospitalization Death Full cohort 11284 (100) 7.0 (6.4–7.5) 23.8 (22.8–24.8) 2941 (26.1) 861 (7.6) Stratified by: Age 18–74 3340 (29.6) 5.3 (4.9–6.2) 43.5 (40.5–47.3) 954 (28.6) 161 (4.8) 75–84 3982 (35.3) 6.6 (5.9–7.5) 25.4 (24.1–27.0) 1079 (27.1) 292 (7.3) 85+ 3962 (35.3) 9.0 (8.0–10.1) 14.1 (13.0–15.1) 908 (22.9) 408 (10.3) Sex Female 6076 (53.8) 8.8 (8.1–9.8) 26.7 (25.5–28.2) 1440 (23.7) 453 (7.5) Male 5208 (46.2) 5.2 (4.8–5.8 ) 20.2 (18.2–21.6) 1501 (28.8) 408 (7.8) Multimorbidity 0 1566 (13.9) 13.4 (11.0–16.0) 33.6 (29.8–36.3) 316 (20.2) 80 (5.1) 1–2 5215 (46.2) 8.7 (8.1–9.8) 27.4 (25.5–29.0) 1261 (24.2) 387 (7.4) 3+ 4503 (39.9) 4.1 (3.7–4.6) 16.7 (15.6–18.1) 1364 (30.3) 394 (8.7) Recent hospitalization No 2544 (22.5) 9.8 (8.6–11.0) 20.7 (18.9–22.8) 553 (21.7) 173 (6.8) Yes 8740 (77.5) 6.2 (5.6–6.8) 24.8 (23.7–25.9) 2388 (27.3) 688 (7.9) 5-year history of Alcohol misuse 832 (7.4) 5.3 (4.1–6.9) 34.7 (30.2–40.6) 236 (28.4) 40 (4.8) Asthma 342 (3.0) 4.8 (2.9–7.3) 27.7 (21.4–36.5) 102 (29.8) 20 (5.8) Atrial fibrillation 2559 (22.7) 4.3 ( 3.6–5.0) 14.5 (12.7–16.0) 757 (29.6) 243 (9.5) Cancer, lymphoma 228 (2.0) 1.7 (1.1–2.7) 7.0 (4.3–9.2) 95 (41.7) 28 (12.3) Cancer, metastatic 483 (4.3) 5.6 (3.1–11.9) 1.6 (1.4–2.1) 160 (33.1) 125 (25.9) Cancer, non–metastatic 1316 (11.7) 5.0 (3.7–6.4) 6.0 (4.7–7.5) 417 (31.7) 205 (15.6) Chronic heart failure 1189 (10.5) 3.3 (2.7–4.1) 10.4 (8.4–13.0) 393 (33.1) 133 (11.2) Chronic kidney disease 1468 (13.0) 3.2 (2.7–3.7) 14.1 (11.9–16.0) 485 (33.0) 136 (9.3) Chronic pain 2025 (17.9) 4.8 (4.0–5.3) 27.7 (25.2–30.5) 562 (27.8) 130 (6.4) Chronic pulmonary disease 15.79 (14.0) 3.7 (3.1–4.7) 13.6 (12.2–15.2) 496 (31.4) 149 (9.4) Cirrhosis 219 (1.9) 1.8 (1.1–3.4) 13.8 (9.2–17.3) 89 (40.6) 14 (6.4) Dementia 1191 (10.6) 13.8 (11.2–16.8) 21.8 (19.1–24.1) 225 (18.9) 82 (6.8) Depression 601 (5.33) 5.1 (4.1–7.1) 26.9 (23.2–30.8) 170 (28.3) 43 (7.1) Diabetes 1850 (16.4) 3.6 (3.1–4.4) 19.7 (17.3–22.4) 603 (32.6) 127 (6.9) Epilepsy 383 (3.4) 4.0 (3.0–5.6) 27.4 (21.1–34.3) 104 (27.2) 21 (5.5) Hypertension 4079 (36.1) 5.3 (5.0–6.0) 22.7 (20.7–24.2) 1120 (27.5) 297 (7.3) Hypothyroidism 394 (3.5) 6.0 (4.4–8.6) 20.5 (14.7–26.8) 103 (26.1) 30 (7.6) Inflammatory bowel disease 114 (1.0) 4.8 (2.2–11.0) 28.8 (23.0–47.9) 37 (32.5) 6 (5.3) Multiple sclerosis 92 (0.8) 5.0 (2.7–9.8) 63.2 (51.4–NR) 26 (28.3) < 5 Myocardial infarction 435 (3.9) 5.4 (3.7–7.5) 18.9 (15.1–25.2) 121 (27.8) 46 (10.6) Parkinson’s disease 336 (3.0) 5.1 (4.0–7.1) 25.5 (21.1–30.4) 88 (26.2) 12 (3.6) Peptic ulcer disease 138 (1.2) 3.8 (2.4–7.2) 18.6 (10.1–25.8) 38 (27.5) 12 (8.7) Peripheral vascular disease 1061 (9.4) 4.2 (3.3–5.3) 16.1 (13.7–18.4) 334 (31.5) 102 (9.6) Psoriasis 98 (0.9) 6.0 (2.8–13.8) 32.5 (20.2–46.8) 23 (23.5) 7 (7.1) Rheumatoid arthritis 395 (3.5) 4.5 (3.0–5.8) 18.8 (13.6–24.8) 118 (29.9) 34 (8.6) Schizophrenia 75 (0.7) 8.2 (3.8–19.3) 48.9 (28.0–NR) 14 (18.7) < 5 Stroke or TIA 2345 (20.8) 6.6 (5.6–7.4) 28.1 (26.1–30.8) 571 (24.3) 146 (6.2) NR = upper confidence limit not reached; the 95% upper confidence band for the survival curve remained above 0.50 for the entire follow-up period. Age, sex, multimorbidity, and recent hospitalization (step 1) In mutually adjusted models (Table 2 ), each 10-year increase in age was associated with lower 30-day absolute risk (adjusted ARR [aARR] 0.96, 95% CI 0.93–0.98). Male patients experienced a higher risk than females (aARR 1.16, 95% CI 1.09–1.24). A clear dose-response with multimorbidity was evident: compared with patients without recorded morbidities, those with 1–2 morbidities had 17% higher 30-day risk (aARR 1.17, 95% CI 1.04–1.31), while patients with ≥ 3 morbidities showed 43% increase (aARR 1.43, 95% CI 1.27–1.61). A recent hospital stay (within seven days before the TS admission) remained an independent predictor, raising 30-day risk (aARR 1.24, 95% CI 1.14–1.34). Longer-term 180-day associations were in the same direction as the 30-day risks, but the effect sizes were smaller in magnitude. Univariate estimates were directionally consistent but slightly larger in magnitude. Table 2 Analysis of the association of age, sex, multimorbidity, and recent hospitalization with consequent hospitalization. 30-day hospitalization 180-day hospitalization Variable in analysis uARR 1 (95% CI) aARR 2 (95% CI) uARR 1 (95% CI) aARR 2 (95% CI) Age * 0.94 (0.92–0.97) 0.96 (0.93–0.98) 0.95 (0.94–0.97) 0.96 (0.95–0.98) Sex Female reference reference reference reference Male 1.22 (1.14–1.29) 1.16 (1.09–1.24) 1.14 (1.1–1.19) 1.09 (1.05–1.14) Morbidity Count 0 reference reference reference reference 1–2 1.20 (1.07–1.34) 1.17 (1.04–1.31) 1.17 (1.09–1.26) 1.15 (1.07–1.24) 3+ 1.50 (1.34–1.69) 1.43 (1.27–1.61) 1.45 (1.34–1.56) 1.40 (1.30–1.51) Recent Hospitalization No reference Reference reference reference Yes 1.26 (1.16–1.36) 1.24 (1.14–1.34) 1.14 (1.09–1.20) 1.13 (1.08–1.19) 1. unadjusted ARR; 2. adjusted ARR by including all four covariates.; * per 10 unit increase in age Morbidities (step 2) As shown in Table 3 , after adjustment for the three core baseline covariates, the most substantial increases in both the 30-day and the 180-day absolute risks were seen for lymphoma, cirrhosis, and chronic kidney disease, followed by atrial fibrillation, chronic heart failure, chronic pulmonary disease, and diabetes. Notably, metastatic and non-metastatic cancers increased the 30-day risk, but their effect on longer-term risk did not reach statistical significance, highlighting a divergence between early readmission propensity and longer-term trajectories. Dementia and stroke/transient ischaemic attack were associated with significantly lower hospitalization risk across both time horizons. The 11 morbidities with significant 30-day ARR ( p < 0.05) were therefore carried forward as additional adjustment factors in subsequent analytic steps, together with the three core baseline covariates. Table 3 Association of selected morbidities with consequent hospitalization. 30-day Hospitalization 180-day Hospitalization Variable in analysis aARR SAM (95% CI) p-value aARR SAM (95% CI) p-value Alcohol misuse 0.93 (0.83–1.05) 0.25 0.93 (0.87–1.00) 0.05 Asthma 1.04 (0.89–1.22) 0.61 0.98 (0.89–1.08) 0.65 Atrial fibrillation* 1.09 (1.01–1.17) 0.04 1.08 (1.03–1.14) < 0.001 Cancer, lymphoma* 1.48 (1.26–1.74) < 0.0001 1.25 (1.13–1.38) < 0.0001 Cancer, metastatic* 1.16 (1.02–1.33) 0.03 0.94 (0.86–1.04) 0.24 Cancer, non-metastatic* 1.15 (1.05–1.25) < 0.01 0.99 (0.94–1.06) 0.95 Chronic heart failure* 1.15 (1.05–1.27) < 0.01 1.12 (1.05–1.18) < 0.001 Chronic kidney disease* 1.17 (1.07–1.28) < 0.001 1.15 (1.09–1.21) < 0.0001 Chronic pain 0.99 (0.91–1.07) 0.76 1.04 (0.99–1.09) 0.07 Chronic pulmonary disease* 1.12 (1.02–1.22) 0.01 1.08 (1.02–1.14) < 0.01 Cirrhosis* 1.34 (1.13–1.59) < 0.001 1.19 (1.07–1.32) < 0.001 Dementia* 0.67 (0.59–0.76) < 0.0001 0.76 (0.71–0.82) < 0.0001 Depression 0.97 (0.85–1.11) 0.69 0.98 (0.91–1.06) 0.68 Diabetes* 1.16 (1.06–1.26) < 0.001 1.09 (1.03–1.14) < 0.01 Epilepsy 0.90 (0.76–1.07) 0.25 1.05 (0.95–1.15) 0.35 Hypertension 0.95 (0.89–1.03) 0.22 0.99 (0.95–1.04) 0.74 Hypothyroidism 0.96 (0.81–1.13) 0.62 0.97 (0.88–1.07) 0.58 Inflammatory bowel disease 1.10 (0.85–1.44) 0.46 0.94 (0.78–1.12) 0.48 Multiple sclerosis 1.02 (0.73–1.41) 0.92 1.04 (0.86–1.25) 0.71 Myocardial infarction 0.95 (0.81–1.11) 0.52 0.96 (0.88–1.06) 0.44 Parkinson’s disease 0.93 (0.77–1.12) 0.45 1.04 (0.94–1.16) 0.43 Peptic ulcer disease 0.95 (0.72–1.25) 0.72 1.04 (0.89–1.22) 0.61 Peripheral vascular disease 1.09 (0.99–1.21) 0.09 1.03 (0.97–1.10) 0.33 Psoriasis 0.77 (0.54–1.10) 0.16 0.89 (0.72–1.09) 0.27 Rheumatoid arthritis 1.08 (0.92–1.26) 0.35 1.08 (0.99–1.19) 0.10 Schizophrenia 0.64 (0.40–1.02) 0.06 0.83 (0.64–1.06) 0.14 Stroke or TIA* 0.83 (0.76–0.90) < 0.0001 0.94 (0.89–0.98) 0.01 aARR SAM = absolute risk ratio adjusted for sex, age, and multimorbidity * Significant morbidities Healthcare-utilization markers (step 3) After adjustment for core baseline and morbidity covariates, each of the three utilization indicators—one-year history of hospitalization burden, polypharmacy, and frequency of surgery—retained an independent association with subsequent hospitalization (Table 4 ). Relative to patients with ≤ 1 inpatient hospital contacts, those with 2–3 contacts exhibited 27% higher 30-day absolute risk (aARR 1.27, 1.13–1.43), while those with ≥ 4 contacts showed an increase of 58% (aARR 1.58, 1.41–1.77). Medication count displayed a similar dose-response: compared with ≤ 4 unique drugs, prescriptions of 5–9 and ≥ 10 drugs were associated with 15% (aARR 1.15, 1.03–1.27) and 28% (aARR 1.28, 1.16–1.42) higher 30-day risks, respectively. Prior surgical activity also predicted hospitalization: one to two procedures conferred an aARR of 1.23 (1.13–1.33), whereas three or more procedures increased the aARR to 1.34 (1.24–1.44). All 180-day associations were smaller in magnitude, and in the case of polypharmacy, prescriptions of 5–9 drugs did not increase the 180-day risk significantly compared with ≤ 4 drugs. Table 4 Association of healthcare-utilization indicators with subsequent hospitalization. 30-day Hospitalization 180-day Hospitalization Variable in analysis Count (%) aARR SAMM (95% CI) p-value aARR SAMM (95% CI) p-value 1-year history of Hospitalizations 0–1 1835 (16.3) reference – reference – 2–3 3885 (34.4) 1.27 (1.13–1.43) < 0.0001 1.10 (1.03–1.18) < 0.01 4+ 5564 (49.3) 1.58 (1.41–1.77) < 0.0001 1.29 (1.21–1.38) < 0.0001 Unique prescriptions 0–4 1919 (17.0) reference – reference – 5–9 3877 (34.4) 1.15 (1.03–1.27) < 0.01 1.06 (0.99–1.13) 0.08 10+ 5488 (48.6) 1.28 (1.16–1.42) < 0.0001 1.20 (1.13–1.28) < 0.0001 Surgical procedures 0 6252 (55.4) reference – reference – 1–2 2454 (21.7) 1.23 (1.13–1.33) < 0.0001 1.10 (1.04–1.15) < 0.001 3+ 2578 (22.8) 1.34 (1.24–1.44) < 0.0001 1.18 (1.13–1.23) < 0.0001 aARR SAMM = absolute risk ratio adjusted for sex, age, multimorbidity, and significant morbidities. Characteristics of the recent hospitalization (step 4) Among the 8740 patients whose index TS admission was preceded by a hospital discharge within seven days, the annual patterns of healthcare use remained influential. However, their impact differed across levels and between early and longer-term readmission horizons (Table 5 ). Three variables that characterized the recent hospital episode also proved informative. A primary diagnosis of fall injury was associated with lower 30-day risk (aARR 0.88, 0.80–0.98) and also lower 180-day risk (aARR 0.92, 0.80–0.98). If that recent stay involved a surgical intervention, 30-day risk increased (aARR 1.09, 1.01–1.18), but the effect on 180-day risk was insignificant. Finally, length of hospital stay displayed a clear trend in the 30-day risk: 8–14 days versus 1–7 days yielded aARR 1.14 (1.05–1.24) and stays exceeding 14 days elevated the risk by 31% (aARR 1.31, 1.19–1.43). Regarding 180-day risk, only stays exceeding 14 days increased the risk (aARR 1.13, 1.07–1.20). Table 5 Association of characteristics of recently-hospitalized patients with subsequent hospitalization (N = 8740). 30-day Hospitalization 180-day Hospitalization Variable in analysis Count (%) aARR SAMM (95% CI) p-value aARR SAMM (95% CI) p-value 1-year history of Hospitalizations 0–1 667 (7.6) reference – reference – 2–3 3307 (37.8) 1.14 (0.96–1.35) 0.14 1.00 (0.91–1.11) 0.97 4+ 4766 (54.5) 1.41 (1.19–1.68) < 0.0001 1.17 (1.06–1.29) < 0.01 Unique prescriptions 0–4 1531 (17.5) reference – reference – 5–9 3038 (34.8) 1.15 (1.02–1.29) 0.02 1.05 (0.98–1.13) 0.17 10+ 4171 (47.7) 1.33 (1.18–1.49) < 0.0001 1.21 (1.12–1.30) < 0.0001 Surgical procedures 0 4514 (51.6) reference – reference – 1–2 2063 (23.6) 1.18 (1.08–1.28) < 0.001 1.05 (1.00–1.11) 0.05 3+ 2163 (24.7) 1.27 (1.16–1.38) < 0.0001 1.14 (1.08–1.20) < 0.0001 Recent hospitalization Fall injury 1752 (20.0) 0.88 (0.80–0.98) 0.02 0.92 (0.87–0.98) 0.01 Surgery 2077 (23.8) 1.09 (1.01–1.18) 0.04 1.04 (0.97–1.09) 0.16 Length of stay 1–7 days 2756 (31.5) reference – reference – 8–14 days 3839 (43.9) 1.14 (1.05–1.24) 14 days 2145 (24.5) 1.31 (1.19–1.43) < 0.0001 1.13 (1.07–1.20) < 0.0001 aARR SAMM = absolute risk ratio adjusted for sex, age, multimorbidity, and significant morbidities. Discriminant ability of risk factors and models Among several combinations of variables used to predict 30-day hospitalization risks in the complete cohort, the full model including sex, age, multimorbidity, recent hospitalization, significant morbidities, and healthcare-utilization markers performed best (see supplementary material–Table A5) with a c-index of 0.6225 (95% CI 0.6108–0.6342) and the Brier score being 0.1861 (95% CI 0.1822–0.1899). In similar risk prediction tasks within the recently hospitalized patients, adding variables of the recent hospitalization episode, i.e., primary diagnosis of fall injury, surgery, and length of stay, did not significantly improve either the c-index ( p = 0.53) or the Brier score ( p = 0.12). The risk regression method used in this study outperformed the Fine-Gray method in most models, and a similar performance was observed in the baseline models including only sex, age, multimorbidity, or recent hospitalization (see supplementary material–Table A6). Discussion We examined risk factors for all-cause 30-day hospital (re)admissions among older patients entering Danish municipal TS facilities. Our study utilized a large cohort of TS patients from 14 municipalities distributed across four out of five regions of Denmark (see supplementary material–Table A1). To our knowledge, this is the first systematic research on baseline risk factors of early hospitalization among Danish TS patients. Overall, our results demonstrated both concordance with and divergences from the existing literature, reflecting unique aspects of the Danish municipal TS and the differences in case-mix and care models worldwide. We found that having multiple chronic conditions was a key determinant of (re)hospitalization. This aligns with a broad literature identifying high comorbidity burdens as a major risk factor for post-acute readmissions [ 18 , 19 , 26 , 27 ]. Similarly, our finding that higher levels of previous health care utilization, including polypharmacy, history of frequent hospitalizations and surgeries, having a recent hospitalization prior to TS admission, and prolonged previous hospital stay, increase the risk of return to acute care corroborates prior research in geriatric cohorts [ 24 , 26 , 36 , 37 ]. The overlap in risk profiles suggests that, regardless of setting, patients with complex medical needs and intense prior healthcare utilization are vulnerable to cycling back to the hospital. Our results showed that male patients have a higher hospitalization risk as observed in several studies on geriatric rehabilitation units in Scotland and the United States [ 25 , 38 , 39 ] and other geriatric cohorts [ 21 , 40 , 41 ]. However, there are other studies in the United States and Australia reporting no association between sex and hospitalization risk [ 23 , 24 , 26 , 42 ]. Although there is no definitive explanation for the increased risk of hospitalization in men, some studies have hypothesized differences in health-seeking behaviors and adherence to treatment as a possible underlying factor [ 25 , 41 ]. One notable divergence from some prior research was the role of age. We observed that increasing age was protective against hospitalization. Another study similarly reported a reduced readmission risk with older age in a rehabilitation setting [ 25 ], contrary to several other studies where advanced age either predicted higher readmissions [ 38 , 39 ] or showed no significant association [ 23 , 24 , 26 , 42 ]. This discrepancy likely reflects selection and competing risk factors. The oldest frail patients in Denmark may be more often transitioned to long-term care or palliative pathways instead of hospital readmission, and some may have higher mortality, which we accounted for as a competing risk. As Fig. 1.b shows, older age groups have a higher probability of mortality without experiencing hospitalization over the 180-day follow-up. Our analysis also highlighted specific chronic conditions associated with increased risk of 30-day hospitalization. We reported that chronic heart failure, atrial fibrillation, lymphoma, metastatic and non-metastatic cancer, chronic pulmonary disease, chronic kidney disease, cirrhosis, and diabetes are associated with increased risk of early hospitalization. These results are well-supported by prior research on both general and older adult populations [ 18 , 24 , 25 , 40 , 43 ]. A notable observation was the insignificant association of metastatic and non-metastatic cancer with longer-term hospitalization risk. In our cohort, patients with metastatic and non-metastatic cancer had very short median survival times (1.6 months and 6 months, respectively). Thus, we speculate that such severe conditions might shift the outcome balance toward mortality or end-of-life care rather than repeat hospitalization. However, this does not explain the consistent increase in risk of 30-day and 180-day hospitalization in patients with lymphoma who also had a short median survival time (7 months). Interestingly, we observed that dementia, previous stroke, and recent fall injuries were associated with lower hospitalization risk, possibly due to selection. In a previous study, dementia and fall injuries were found to be protective against early mortality in TS patients, highlighting the possibility that these patients are admitted to TS for less critical needs [ 13 ]. The identified risk factors in our study point to both disease-specific and general care gaps that may inform interventions to preempt early rehospitalization among high-risk TS patients, though this is a challenging task. Previous research has shown that most interventions aimed at reducing hospital readmissions did not affect readmission rates [ 44 – 46 ]. A systematic review on the impact of transitional care interventions on hospital readmission in older medical patients reported that most successful interventions were of high intensity, lasted at least one month, and specifically targeted patients at risk [ 6 ]. Some disease-specific interventions have been successful in reducing early readmissions, e.g., for patients with heart failure [ 47 ], chronic pulmonary disease [ 48 ], or kidney disease [ 49 ]. However, evidence from a nationwide cohort study on older acutely admitted patients in Denmark revealed that roughly 73% of readmitted patients returned to hospital for a different reason than the previous diagnosis [ 21 ]. Therefore, targeting a single disease may not be an effective approach on its own. Additionally, given the low specialization level of Danish TS facilities, implementing interventions for every disease-specific risk factor may not be practical. Meanwhile, holistic interventions could mitigate the cumulative risk from multimorbidity, and healthcare utilization factors. For instance, medication review and deprescribing have shown reductions in readmission rates among older adults [ 50 ], and multidisciplinary geriatric assessment teams in transitional care can reduce subsequent acute care use [ 5 , 51 ]. Notably, evidence from a single Danish TS facility shows that follow-up visits by an outgoing multidisciplinary geriatric team significantly reduced 30-day readmission [ 51 ]. A major strength of our analysis was the use of competing risk framework. Given that the 30-day mortality rate in our population was not negligible when compared with the 30-day hospitalization rate (8% versus 26%), we employed competing risk models to account for the outcome of death preventing the occurrence of hospitalizations. Many studies omit competing risk analyses out of convenience or convention. However, violating the assumption of noninformative censoring, i.e., treating death as censoring, can lead to biased results by overestimating the risk of the main event of interest, especially in older, multimorbid populations [ 52 , 53 ]. A review of 100 studies published in prominent medical journals concluded that 46% were susceptible to competing risk bias [ 54 ], highlighting the importance of using competing risk models for accurate risk estimation. Furthermore, our use of additive competing risks regression modeling to directly estimate the absolute risk ratios improves the interpretability of results compared to other methods reporting associations on the hazard scale. The results of this study must be viewed in light of its limitations. Several important predictors identified in prior studies were not evaluated in our analysis due to data limitations. Functional ability, cognitive status, living alone, social support, and other socioeconomic factors were not captured, though evidence suggests each may affect patient outcomes [ 55 – 58 ]. Also, the reasons for recent hospitalization (primary diagnoses) before TS admission were sparsely distributed as previously reported [ 13 ], and therefore, we did not evaluate their potentially important role in readmissions. The only indicators we extracted from recent hospitalization episodes were primary diagnosis of fall injuries, surgical interventions, and length of stay at hospital. Furthermore, TS facility quality indicators were not investigated in this study. As a decentralized care setting, TS facilities vary in size, staffing mix, and the type of services they offer [ 12 ] and there is evidence that patient characteristics and trajectories vary across municipalities [ 13 ]. Another limitation of this study is the focus on all-cause hospitalizations without considering whether they were unplanned or preventable. All of these limitations are known to negatively affect the performance of most hospital readmission risk prediction models, resulting in relatively poor discriminant ability [ 59 , 60 ] as observed in our study. Finally, despite using a large cohort across multiple Danish municipalities and regions, our results may not be generalizable to other intermediate care settings due to the diverse and fragmented implementation of intermediate care globally [ 5 ]. Conclusion Early (re)hospitalization after admission to Danish municipal temporary stay facilities was common (26.1% within 30 days) and occurred alongside substantial early mortality (7.6%), underscoring the need for robust transitional care in this setting. Risk was patterned by male sex, higher multimorbidity, recent hospitalization, and markers of intensive prior healthcare use (polypharmacy, repeated admissions, surgical procedures). In contrast, advancing age, dementia, and prior stroke/TIA were associated with lower risk. In recently hospitalized patients, a fall-injury index diagnosis lowered 30-day risk, while recent surgery and hospital stays > 14 days increased it. Although discrimination was modest (c-index ~ 0.62), the identified predictors can support risk stratification to prioritize higher-intensity transitional support (e.g., medication review/deprescribing, multidisciplinary geriatric outreach) for those most likely to return to hospital. Future research should integrate functional status, cognitive and social determinants, and TS facility characteristics, and distinguish unplanned or potentially preventable readmissions to sharpen prediction and guide targeted, scalable interventions in TS. Abbreviations TS Temporary stay CPR Central Person Register ICD International classification of diseases DNPR Danish National Patient Registry SKS Sundhedsvæsenets klassifikationssystem (Health care classification system) ATC Anatomical therapeutic chemical classification CIF Cumulative incidence function CI Confidence interval ARR Absolute risk ratio uARR Unadjusted absolute risk ratio aARR Adjusted absolute risk ratio IFPW Inverse failure probability weighting IQR Interquartile range TIA Transient ischaemic attack Declarations Acknowledgements Not applicable. Authors’ contribution MR, KK, and KE conceptualized and designed the study. MR performed the statistical analysis and wrote the manuscript. MR and AP interpreted the results. KK, KE, and AP have read and commented on the manuscript. All authors have read and approved the final version of the manuscript for submission. Funding The study was funded by Novo Nordisk Foundation (grant number 0075454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Availability of data and material Danish legislation does not allow individual-level data to be publicly available. Anonymized data can be accessed by authorized researchers after application to Forskeservice at the Danish Health Data Authority. MR had full access to the data. Coding scripts for the analysis are available upon request. Ethics approval and consent to participate This research project has been conducted in accordance with the principles of the Helsinki Declaration and further adheres to the legal requirements of the study country. This study was register-based, only anonymized data was used, data is presented in aggregate and anonymous form, and study participants were not contacted nor required any active participation. According to Danish law, approval from an ethics committee and informed consent to participate are not required for register-based studies (section 14.2 of the Act on Research Ethics Review of Health Research Projects and section 10 of the Data Protection Act). In terms of data protection, the study was registered at the University of Southern Denmark inventory (record no. 11.436). Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Author details 1 Department of Engineering Technology and Didactics, Technical University of Denmark, Ballerup, Denmark. 2 Department of Public Health, University of Southern Denmark, Odense, Denmark. 3 Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark. References Takahashi PY, Leppin AL, Hanson GJ. Hospital to Community Transitions for Older Adults. Mayo Clin Proc. 2020;95:2253–62. https://doi.org/10.1016/j.mayocp.2020.02.001 Lowthian J. How do we optimise care transition of frail older people? Age Ageing. 2016. https://doi.org/10.1093/ageing/afw171 . :ageing;afw171v1. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ Can Med Assoc J J Assoc Medicale Can. 2004;170:345–9. Sezgin D, O’Caoimh R, O’Donovan MR, Salem MA, Kennelly S, Samaniego LL, et al. Defining the characteristics of intermediate care models including transitional care: an international Delphi study. Aging Clin Exp Res. 2020;32:2399–410. https://doi.org/10.1007/s40520-020-01579-z . Sezgin D, O’Caoimh R, Liew A, O’Donovan MR, Illario M, Salem MA, et al. The effectiveness of intermediate care including transitional care interventions on function, healthcare utilisation and costs: a scoping review. Eur Geriatr Med. 2020;11:961–74. https://doi.org/10.1007/s41999-020-00365-4 . Fønss Rasmussen L, Grode LB, Lange J, Barat I, Gregersen M. Impact of transitional care interventions on hospital readmissions in older medical patients: a systematic review. BMJ Open. 2021;11:e040057. https://doi.org/10.1136/bmjopen-2020-040057 . Herfjord JK, Heggestad T, Ersland H, Ranhoff AH. Intermediate care in nursing home after hospital admission: a randomized controlled trial with one year follow-up. BMC Res Notes. 2014;7:889. https://doi.org/10.1186/1756-0500-7-889 . Liapi F, Chater AM, Kenny T, Anderson J, Randhawa G, Pappas Y. Evaluating step-down, intermediate care programme in Buckinghamshire, UK: a mixed methods study. BMC Public Health. 2023;23:1087. https://doi.org/10.1186/s12889-023-15868-5 . Morando V, Holditch C, Inzitari M, Tozzi V, Hendry A. Understanding intermediate care development, supporting implementation and scaling up of intermediate care in Europe. Int J Integr Care. 2016;16:367. https://doi.org/10.5334/ijic.2915 . The Danish Organization of General Practitioners and Local Government Denmark. Definition af midlertidige døgndækkede pladser [Definition of temporary 24-hour placements]. https://stps.dk/Media/638257904106148719/plo_og_kl_-_definition_af_midlertidige_d-gnd-kkede.pdf . Accessed 31 July 2025. Kayser K, Christensen MR. Municipality of Copenhagen. Status vedr. midlertidige døgnophold [Status regarding temporary stays]. 2021. https://www.kk.dk/dagsordener-og-referater/Sundheds-%20og%20Omsorgsudvalget/m%C3%B8de-22062021/referat/punkt-3 . Accessed 31 July 2025. Vinge S, Buch MS, Kjellberg PK. Det kommunale akutområde: Erfaringer og perspektiver på udviklingen fra 15 kommuner [The municipal emergency area - Experiences and perspectives on the development from 15 municipalities]. The Danish Center for Social Science Research. 2021. https://www.vive.dk/media/pure/16209/5709970 . Accessed 31 July 2025. Harbi H, Lundby C, Jensen PB, Larsen SP, Rørbæk LG, Ravn-Nielsen LV, et al. Characteristics and care trajectories of older patients in temporary stays in Denmark. Eur Geriatr Med. 2025. https://doi.org/10.1007/s41999-025-01209-9 . Harbi H, Lundby C, Jensen PB, Larsen SP, Rørbæk LG, Ravn-Nielsen LV, et al. Medication use patterns among older patients in temporary stays in Denmark. Eur Geriatr Med. 2025. https://doi.org/10.1007/s41999-025-01210-2 . Pugh J, Penney LS, Noël PH, Neller S, Mader M, Finley EP, et al. Evidence based processes to prevent readmissions: more is better, a ten-site observational study. BMC Health Serv Res. 2021;21. https://doi.org/10.1186/s12913-021-06193-x . Weissman JS, Ayanian JZ, Chasan-Taber S, Sherwood MJ, Roth C, Epstein AM. Hospital Readmissions and Quality of Care. Med Care. 1999;37. Balla U, Malnick S, Schattner A. Early Readmissions to the Department of Medicine as a Screening Tool for Monitoring Quality of Care Problems. Med (Baltim). 2008;87:294–300. https://doi.org/10.1097/md.0b013e3181886f93 . Cilla F, Sabione I, D’Amelio P. Risk Factors for Early Hospital Readmission in Geriatric Patients: A Systematic Review. Int J Environ Res Public Health. 2023;20:1674. https://doi.org/10.3390/ijerph20031674 . Glans M, Kragh Ekstam A, Jakobsson U, Bondesson Å, Midlöv P. Risk factors for hospital readmission in older adults within 30 days of discharge – a comparative retrospective study. BMC Geriatr. 2020;20. https://doi.org/10.1186/s12877-020-01867-3 . Willers C, Boström A-M, Carlsson L, Lager A, Lindqvist R, Rydwik E. Readmission within three months after inpatient geriatric care—Incidence, diagnosis and associated factors in a Swedish cohort. PLoS ONE. 2021;16:e0248972. https://doi.org/10.1371/journal.pone.0248972 . Klinge M, Aasbrenn M, Öztürk B, Christiansen CF, Suetta C, Pressel E, et al. Readmission of older acutely admitted medical patients after short-term admissions in Denmark: a nationwide cohort study. BMC Geriatr. 2020;20. https://doi.org/10.1186/s12877-020-01599-4 . Rasmussen MG, Ravn P, Molsted S, Tarnow L, Rosthøj S. Readmission to hospital of medical patients – A cohort study. Eur J Intern Med. 2017;46:19–24. https://doi.org/10.1016/j.ejim.2017.07.008 . Dombrowski W, Yoos JL, Neufeld R, Tarshish CY. Factors Predicting Rehospitalization of Elderly Patients in a Postacute Skilled Nursing Facility Rehabilitation Program. Arch Phys Med Rehabil. 2012;93:1808–13. https://doi.org/10.1016/j.apmr.2012.04.018 . Burke RE, Whitfield EA, Hittle D, Min S, Levy C, Prochazka AV, et al. Hospital Readmission From Post-Acute Care Facilities: Risk Factors, Timing, and Outcomes. J Am Med Dir Assoc. 2016;17:249–55. https://doi.org/10.1016/j.jamda.2015.11.005 . Hughes LD, Witham MD. Causes and correlates of 30 day and 180 day readmission following discharge from a Medicine for the Elderly Rehabilitation unit. BMC Geriatr. 2018;18. https://doi.org/10.1186/s12877-018-0883-3 . Wan CS, Reijnierse EM, Maier AB. Risk Factors of Readmissions in Geriatric Rehabilitation Patients: RESORT. Arch Phys Med Rehabil. 2021;102:1524–32. https://doi.org/10.1016/j.apmr.2021.01.082 . Griffin O, Li T, Beveridge A, Ní Chróinín D. Higher levels of multimorbidity are associated with increased risk of readmission for older people during post-acute transitional care. Eur Geriatr Med. 2023;14:575–82. https://doi.org/10.1007/s41999-023-00770-5 . Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–9. https://doi.org/10.1007/s10654-014-9930-3 . Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;449. https://doi.org/10.2147/CLEP.S91125 . Danish Health Data Authority. Sundhedsvæsenets Klassifikationssystem [Health Care Classification System]. https://sundhedsdatastyrelsen.dk/indberetning/klassifikationer/sks-klassifikationer . Accessed 30 July 2025. Danish Health Data Authority. SKS Browser. https://medinfo.dk/sks/brows.php . Accessed 30 July 2025. Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data Resource Profile: The Danish National Prescription Registry. Int J Epidemiol. 2016;dyw213. https://doi.org/10.1093/ije/dyw213 . Aalen OO, Johansen S. An Empirical Transition Matrix for Non-Homogeneous Markov Chains Based on Censored Observations. Scand J Stat. 1978;5:141–50. Scheike TH, Zhang M-J. Lifetime Data Anal. 2008;14:464–83. https://doi.org/10.1007/s10985-008-9094-0 . Flexible competing risks regression modeling and goodness-of-fit. Robins JM, Rotnitzky A, Zhao LP. Estimation of Regression Coefficients When Some Regressors are not Always Observed. J Am Stat Assoc. 1994;89:846–66. https://doi.org/10.1080/01621459.1994.10476818 . Franchi C, Nobili A, Mari D, Tettamanti M, Djade CD, Pasina L, et al. Risk factors for hospital readmission of elderly patients. Eur J Intern Med. 2013;24:45–51. https://doi.org/10.1016/j.ejim.2012.10.005 . Prediction of potentially. avoidable readmission risk in a division of general internal medicine. Swiss Med Wkly. 2017;147. https://doi.org/10.4414/smw.2017.14470 . Ottenbacher KJ, Karmarkar A, Graham JE, Kuo Y-F, Deutsch A, Reistetter TA, et al. Thirty-Day Hospital Readmission Following Discharge From Postacute Rehabilitation in Fee-for-Service Medicare Patients. JAMA. 2014;311:604. https://doi.org/10.1001/jama.2014.8 . Jencks SF, Williams MV, Coleman EA. Rehospitalizations among Patients in the Medicare Fee-for-Service Program. N Engl J Med. 2009;360:1418–28. https://doi.org/10.1056/nejmsa0803563 . Silverstein MD, Qin H, Mercer SQ, Fong J, Haydar Z. Risk Factors for 30-Day Hospital Readmission in Patients ≥ 65 Years of Age. Bayl Univ Med Cent Proc. 2008;21:363–72. https://doi.org/10.1080/08998280.2008.11928429 Woz S, Mitchell S, Hesko C, Paasche-Orlow M, Greenwald J, Chetty VK, et al. Gender as risk factor for 30 days post-discharge hospital utilisation: a secondary data analysis. BMJ Open. 2012;2:e000428. https://doi.org/10.1136/bmjopen-2011-000428 . Cimarolli VR, Falzarano F, Hicks S. Predictors of Rehospitalization in Post-Acute Rehabilitation among Different Ethnic Groups. J Am Med Dir Assoc. 2020;21:513–8. https://doi.org/10.1016/j.jamda.2019.10.008 . Bogaisky M, Dezieck L. Early Hospital Readmission of Nursing Home Residents and Community-Dwelling Elderly Adults Discharged from the Geriatrics Service of an Urban Teaching Hospital: Patterns and Risk Factors. J Am Geriatr Soc. 2015;63:548–52. https://doi.org/10.1111/jgs.13317 . Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to Reduce 30-Day Rehospitalization: A Systematic Review. Ann Intern Med. 2011;155:520–8. https://doi.org/10.7326/0003-4819-155-8-201110180-00008 . Linertová R, García-Pérez L, Vázquez-Díaz JR, Lorenzo-Riera A, Sarría-Santamera A. Interventions to reduce hospital readmissions in the elderly: in-hospital or home care. A systematic review: Prevention of readmissions in the elderly. J Eval Clin Pract. 2011;17:1167–75. https://doi.org/10.1111/j.1365-2753.2010.01493.x . Pannick S, Davis R, Ashrafian H, Byrne BE, Beveridge I, Athanasiou T, et al. Effects of Interdisciplinary Team Care Interventions on General Medical Wards: A Systematic Review. JAMA Intern Med. 2015;175:1288. https://doi.org/10.1001/jamainternmed.2015.2421 . Al Sattouf A, Farahat R, Khatri AA. Effectiveness of Transitional Care Interventions for Heart Failure Patients: A Systematic Review With Meta-Analysis. Cureus. 2022. https://doi.org/10.7759/cureus.29726 . Press VG, Myers LC, Feemster LC. Preventing COPD Readmissions Under the Hospital Readmissions Reduction Program. Chest. 2021;159:996–1006. https://doi.org/10.1016/j.chest.2020.10.008 . Mathew AT, Strippoli GFM, Ruospo M, Fishbane S. Reducing hospital readmissions in patients with end-stage kidney disease. Kidney Int. 2015;88:1250–60. https://doi.org/10.1038/ki.2015.307 . Carollo M, Crisafulli S, Vitturi G, Besco M, Hinek D, Sartorio A, et al. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis. J Am Geriatr Soc. 2024;72:3219–38. https://doi.org/10.1111/jgs.19035 . Thomsen K, Fournaise A, Matzen LE, Andersen-Ranberg K, Ryg J. Does geriatric follow-up visits reduce hospital readmission among older patients discharged to temporary care at a skilled nursing facility: a before-and-after cohort study. BMJ Open. 2021;11:e046698. https://doi.org/10.1136/bmjopen-2020-046698 . Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing Risk of Death: An Important Consideration in Studies of Older Adults. J Am Geriatr Soc. 2010;58:783–7. https://doi.org/10.1111/j.1532-5415.2010.02767.x . Szychowski JM, Roth DL, Clay OJ, Mittelman MS. Patient death as a censoring event or competing risk event in models of nursing home placement. Stat Med. 2010;29:371–81. https://doi.org/10.1002/sim.3797 . Van Walraven C, McAlister FA. Competing risk bias was common in Kaplan–Meier risk estimates published in prominent medical journals. J Clin Epidemiol. 2016;69:170–e1738. https://doi.org/10.1016/j.jclinepi.2015.07.006 . Shih SL, Zafonte R, Bates DW, Gerrard P, Goldstein R, Mix J, et al. Functional Status Outperforms Comorbidities as a Predictor of 30-Day Acute Care Readmissions in the Inpatient Rehabilitation Population. J Am Med Dir Assoc. 2016;17:921–6. https://doi.org/10.1016/j.jamda.2016.06.003 . Anderson RE, Birge SJ. Cognitive Dysfunction, Medication Management, and the Risk of Readmission in Hospital Inpatients. J Am Geriatr Soc. 2016;64:1464–8. https://doi.org/10.1111/jgs.14200 . Barrenetxea J, Tan KB, Tong R, Chua K, Feng Q, Koh W-P, et al. Emergency hospital admissions among older adults living alone in the community. BMC Health Serv Res. 2021;21:1192. https://doi.org/10.1186/s12913-021-07216-3 . Joynt Maddox KE, Reidhead M, Hu J, Kind AJH, Zaslavsky AM, Nagasako EM, et al. Adjusting for social risk factors impacts performance and penalties in the hospital readmissions reduction program. Health Serv Res. 2019;54:327–36. https://doi.org/10.1111/1475-6773.13133 . Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, et al. Risk Prediction Models for Hospital Readmission: A Systematic Review. JAMA. 2011;306:1688. https://doi.org/10.1001/jama.2011.1515 . Zhou H, Della PR, Roberts P, Goh L, Dhaliwal SS. Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open. 2016;6:e011060. https://doi.org/10.1136/bmjopen-2016-011060 . Additional Declarations No competing interests reported. Supplementary Files AdditionalFiles1.docx Cite Share Download PDF Status: Published Journal Publication published 13 Jan, 2026 Read the published version in BMC Health Services Research → Version 1 posted Editorial decision: Revision requested 29 Nov, 2025 Reviews received at journal 13 Nov, 2025 Reviews received at journal 24 Oct, 2025 Reviewers agreed at journal 11 Oct, 2025 Reviewers agreed at journal 09 Oct, 2025 Reviewers invited by journal 09 Oct, 2025 Editor invited by journal 01 Oct, 2025 Editor assigned by journal 30 Sep, 2025 Submission checks completed at journal 30 Sep, 2025 First submitted to journal 29 Sep, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7740773","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":531947646,"identity":"f64ac0bc-5ba1-476d-a542-70586b76d4a4","order_by":0,"name":"Mahan Rajaeigolsefidi","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAApUlEQVRIiWNgGAWjYFACHhC2YWwAUpINJGhJY+whUQvDYRK06LafPfbhh8x52f0SCYw3ZxCjxexMXvLMHp7bxj0SCcyWG4jSciDHmIGH53YiUAub5AOitJx/Y8z4h+ccKVpu5Bgz8/AcgGghzmE33hgzy/AkG/ecedhsSZz3z+cYM77tsZNtb08+eLOHGC1gAI4UBnACIBr8IEXxKBgFo2AUjDgAAJ3JMoLfZ1QkAAAAAElFTkSuQmCC","orcid":"","institution":"Technical University of Denmark","correspondingAuthor":true,"prefix":"","firstName":"Mahan","middleName":"","lastName":"Rajaeigolsefidi","suffix":""},{"id":531947647,"identity":"e69faa1b-30d7-4995-83bd-01f5b5574023","order_by":1,"name":"Anton Pottegård","email":"","orcid":"","institution":"University of Southern Denmark","correspondingAuthor":false,"prefix":"","firstName":"Anton","middleName":"","lastName":"Pottegård","suffix":""},{"id":531947648,"identity":"538aed5d-f39e-49a2-9afd-2656d092f739","order_by":2,"name":"Kasper Edwards","email":"","orcid":"","institution":"Technical University of Denmark","correspondingAuthor":false,"prefix":"","firstName":"Kasper","middleName":"","lastName":"Edwards","suffix":""},{"id":531947649,"identity":"65d2ba04-331c-4771-b076-5fdf8bfdcb84","order_by":3,"name":"Kathrin Kirchner","email":"","orcid":"","institution":"Technical University of Denmark","correspondingAuthor":false,"prefix":"","firstName":"Kathrin","middleName":"","lastName":"Kirchner","suffix":""}],"badges":[],"createdAt":"2025-09-29 10:08:24","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7740773/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7740773/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1186/s12913-026-14045-9","type":"published","date":"2026-01-13T16:29:56+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":94214674,"identity":"4ff7e358-dbb9-4903-8e8f-7a1873847171","added_by":"auto","created_at":"2025-10-23 16:16:50","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":124158,"visible":true,"origin":"","legend":"","description":"","filename":"BMCHSRMRfinalr00.docx","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/9e73a15729110c008f750efe.docx"},{"id":94214169,"identity":"78205399-fc9c-4fb8-a5d2-403705eb6f44","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"json","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":7147,"visible":true,"origin":"","legend":"","description":"","filename":"5a3f59c6c6784a9c87702e7a02c940e7.json","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/af1cfeb7be1114027fb4f9d8.json"},{"id":94214167,"identity":"1b6fefac-a7af-4034-8d57-39f2c9c6d36f","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":29654,"visible":true,"origin":"","legend":"","description":"","filename":"AdditionalFiles1.docx","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/6f4b9111dabbe7a9b327c868.docx"},{"id":94214174,"identity":"412aaed3-18c0-4c12-aeed-486542491e22","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"xml","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":196221,"visible":true,"origin":"","legend":"","description":"","filename":"5a3f59c6c6784a9c87702e7a02c940e71enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/7588e395eea4379afe234ce4.xml"},{"id":94214170,"identity":"1130aedb-1592-42a8-9df5-a21f38b4407f","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"pdf","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":102155,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/52ec48b90b90f86d1e692a86.pdf"},{"id":94214172,"identity":"cdc9236d-99a2-4b8c-9f24-f134590c4299","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"xml","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":195496,"visible":true,"origin":"","legend":"","description":"","filename":"5a3f59c6c6784a9c87702e7a02c940e71structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/41b24820c63e46491536712e.xml"},{"id":94214173,"identity":"134a4b8b-3955-49cf-b6d7-374fb8d9bb52","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"html","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":202412,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/c2cc96bc89b1af34c15d0344.html"},{"id":94214168,"identity":"476d4c35-e1b7-4a2f-b4ea-545c9a222275","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":48284,"visible":true,"origin":"","legend":"\u003cp\u003eStratified cumulative incidence functions (95% CI band) of hospitalization and the competing outcome of death.\u003c/p\u003e","description":"","filename":"Figure1.png","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/8004b13e289132d7231e472d.png"},{"id":100614738,"identity":"b8442e78-2f9c-4ef7-a3fd-23cc5e8d7b30","added_by":"auto","created_at":"2026-01-19 17:23:42","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1645303,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/90a48779-2ecc-4553-836e-11b93c81b4f0.pdf"},{"id":94214166,"identity":"fd6714f5-97e3-47e4-b241-b74a020b10e9","added_by":"auto","created_at":"2025-10-23 16:08:50","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":29654,"visible":true,"origin":"","legend":"","description":"","filename":"AdditionalFiles1.docx","url":"https://assets-eu.researchsquare.com/files/rs-7740773/v1/b509a3d33e28a430d562dd03.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Baseline risk factors associated with all-cause early hospitalization of older patients following admission to Danish municipal temporary stays","fulltext":[{"header":"Background","content":"\u003cp\u003eCare transitions across healthcare settings are widely recognized as high-risk events, particularly for frail older patients [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. Older adults often have complex health and social needs, and many experience complications leading to elevated adverse outcomes such as hospital readmissions [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. In response, health systems worldwide have developed intermediate or transitional care services to support patients during the post-acute period and mitigate these risks. Such services are designed to ensure continuity and coordination of care as patients transfer from hospital to the community, aiming to improve outcomes and prevent avoidable (re)hospitalizations [\u003cspan additionalcitationids=\"CR5\" citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. These intermediate care models, variously termed hospital-at-home, step-down units, community rehabilitation beds, or other names, provide short-term, restorative care at the interface between hospital and home [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan additionalcitationids=\"CR8\" citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eIn Denmark, municipal temporary stay (TS) facilities have been established across all 98 municipalities as an intermediate care solution for older patients who require short-term care that cannot be provided in their home. These facilities offer bed-based, 24-hour support typically after hospital discharge, though some patients are admitted directly from the community [\u003cspan additionalcitationids=\"CR11 CR12\" citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. No centralized national guidelines for TS operations exist, and each municipality organizes its facilities independently. TS units are typically not required to have physicians on site, with medical responsibility falling to the patient\u0026rsquo;s general practitioner or the discharging hospital [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eDespite the expansion of TSs as a key component of health care in Denmark, empirical research on TS patient populations has been limited until recently. Two recent studies have begun to shed light on this patient group using a large cohort of 11,424 TS patients [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e, \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. The first study described medication use patterns [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e], finding a median of 6 different drug classes used per patient, and that 68% of patients were on polypharmacy (\u0026ge;\u0026thinsp;5 drug classes) at admission. High-risk medications were common, and the rate of new drug initiations spiked sharply upon entry into TS facilities. A second study explored TS patients\u0026rsquo; baseline characteristics and trajectories [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e], revealing a heterogeneous profile of advanced age (median 81 years), high comorbidity burden, and substantial prior healthcare utilization. About 70% of TS admissions followed directly after a hospital discharge, and the remaining 30% were admitted from the community. Notably, intermediate care did not eliminate the need for acute hospital care: 7% of patients in the cohort were transferred to a hospital during their TS episode, typically within the first two weeks of their stay, and in total, about 20% experienced a hospital admission within 30 days after discharge from TS. Although the baseline risk factors for 30-day mortality were analyzed, the study did not investigate the correlates of hospital admissions.\u003c/p\u003e\u003cp\u003eHealth services research consistently uses readmission rates as an indicator of care quality and transition success [\u003cspan additionalcitationids=\"CR16\" citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. Although studying risk factors of readmissions after hospital discharge has received noticeable attention internationally and in Denmark [\u003cspan additionalcitationids=\"CR19 CR20 CR21\" citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e], risk factors of hospitalization in older adults admitted to intermediate and transitional care facilities are sparsely described [\u003cspan additionalcitationids=\"CR24 CR25 CR26\" citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e]. Notably, we found no studies investigating hospitalization risk factors in Danish municipal TS patients. Due to the diverse and fragmented implementation of intermediate care structures worldwide and the potential differences in patient populations and care settings [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e], analyzing adverse outcomes in each intermediate care structure is necessary to provide insights into key targets of future interventions. This study aims to identify baseline risk factors for 30-day and 180-day hospitalizations after admission to Danish municipal TS facilities.\u003c/p\u003e"},{"header":"Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e\u003ch2\u003eStudy design\u003c/h2\u003e\u003cp\u003eWe performed an observational, register-based cohort study using routinely collected Danish health and administrative data. The analysis focused on adults with at least one TS admission between January 1, 2016, and December 31, 2023, in any of the 14 participating Danish municipalities (see supplementary material\u0026ndash;Table A1 for a detailed list of municipalities).\u003c/p\u003e\u003c/div\u003e\n\u003ch3\u003eData sources\u003c/h3\u003e\n\u003cp\u003eAll records were linked at the individual level via the unique Central Person Register (CPR) number. Municipal TS records provided admission and discharge dates; the Civil Registration System supplied demographic characteristics (date of birth, sex) together with migration and death dates [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]; hospital contacts and ICD-10 discharge diagnoses were retrieved from the Danish National Patient Registry (DNPR) [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e], and Health Care Classification System (SKS) procedure codes within the DNPR identified surgical interventions [\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e, \u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e]; finally, information on dispensed prescriptions, coded according to the Anatomical Therapeutic Chemical (ATC) scheme, was obtained from the Danish National Prescription Registry [\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e]. All registries are nationwide, continuously updated, and regarded as virtually complete for the variables included.\u003c/p\u003e\n\u003ch3\u003eAssembly of the analytic cohort and follow-up\u003c/h3\u003e\n\u003cp\u003eThe source population comprised 11,584 individuals with at least one TS episode falling entirely within the 2016\u0026ndash;2023 window. We excluded 300 persons who had lived outside Denmark at any point during the five years preceding their first TS admission because their registry histories were potentially incomplete, leaving a final cohort of 11,284 patients. Patients with multiple stays contributed only their first episode. This approach yielded one observation per individual. The end of observation was April 4, 2024. Patients were followed prospectively until the first hospitalization episode or death after the index TS admission date, or until the end of observation, whichever came first.\u003c/p\u003e\n\u003ch3\u003eVariables\u003c/h3\u003e\n\u003cp\u003eThe primary outcome variable of interest was all-cause hospitalization within 30 days after the index TS admission. However, to investigate longer-term associations and the potential differences in short-term versus longer-term trajectories, we also analyzed 180-day hospitalization and the associated risk factors. We included death as a competing outcome. Sex, as assigned at birth, and age at the time of index TS admission were included as demographic variables. A set of 27 morbidities was identified using the 5-year diagnosis history of inpatient hospital contacts. The ICD-10 mapping of morbidities is presented in supplementary material\u0026ndash;Table A2. Multimorbidity was defined as the number of morbidities identified in each patient. Recent hospitalization, a binary variable, was defined as whether the patient had a hospitalization that ended within seven days prior to the index TS admission. Hospitalization burden, polypharmacy, and frequency of surgeries were calculated, respectively, as the number of hospitalizations, unique prescribed medications at the fourth ATC level, and surgical interventions within one year before the index TS admission. When identifying surgical procedures, we excluded specific SKS codes as presented in the supplementary material\u0026ndash;Table A3.\u003c/p\u003e\u003cp\u003eFor patients with a recent hospitalization, we calculated three variables derived from their recent hospitalization episode. We identified fall injuries based on the primary diagnoses of recent hospitalizations using ICD-10 mapping of supplementary material\u0026ndash;Table A4. We also determined whether a patient had undergone surgical interventions during a recent hospitalization. The length of stay of the recent hospitalization episode was also calculated. If a patient had more than one recent hospitalization per definition, we calculated the cumulative length of stay.\u003c/p\u003e\n\u003ch3\u003eAnalytic process\u003c/h3\u003e\n\u003cp\u003eAll calculations and analyses were performed using R version 4.4.3. We obtained cumulative incidence functions (CIFs) of hospitalization, considering death as a competing outcome, using the Aalen-Johansen method [\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e]. The Aalen-Johansen CIFs, stratified by sex, age group, multimorbidity level, and recent hospitalization, were plotted for the first 180 days after the index TS admission. We used the estimations of CIF to calculate median time-to-hospitalization, and via bootstrapping with 1000 resamples, we derived the 95% confidence intervals (CI). We employed the Kaplan-Meier method to calculate the median time-to-death, and the 95% CIs were constructed using the log-minus-log transformation method. These time-to-event estimates, together with counts and proportions of 30-day hospitalization and death, were reported stratified by sex, age group, multimorbidity level, recent hospitalization, and individual selected morbidities. Throughout the rest of the analysis, we assessed the association of different variables with short-term and longer-term future hospitalization, using the 30-day and 180-day absolute risk ratios (ARRs).\u003c/p\u003e\u003cp\u003eARRs were estimated using an additive absolute risk regression model developed by Scheike and Zhang [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e]. This approach directly models absolute risk over time, rather than cause-specific hazards, allowing for intuitive interpretation of relative risks. The model accounts for competing risks and adjusts for confounding using inverse failure probability weighting (IFPW), which corrects for censoring by reweighting individuals according to the inverse probability of remaining uncensored [\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e]. The censoring distribution required for IFPW was estimated using the Kaplan-Meier method. Although patients were potentially followed beyond 30 or 180 days, follow-up data after each time window did not contribute to the respective estimated risks. The 95% CIs were derived from robust sandwich variance estimators, based on asymptotic distribution of the estimating equations [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eWhen conducting risk regression, including all variables simultaneously would adjust for factors that are plausibly on the causal pathway, yielding controlled direct rather than total effects and risking overadjustment or collider bias. We therefore used a pre-specified block-wise strategy. The analysis of risk factors associated with hospitalization after TS admission was conducted in four steps. First, age, sex, multimorbidity, and recent hospitalization were evaluated using both univariate models and an adjusted model including all four variables. Second, the association of each morbidity with hospitalization was assessed adjusting for age, sex, and multimorbidity as the core baseline covariates. Morbidities for which we found significant 30-day ARRs (p\u0026thinsp;\u0026lt;\u0026thinsp;0.05) were then added to the covariates list for future steps. Third, the association of healthcare utilization markers, including one-year history of hospitalization burden, polypharmacy, and frequency of surgery, was analyzed adjusting for the full set of covariates determined in previous steps. Finally, in the fourth step, we only included the subset of the cohort with a recent hospitalization prior to the index TS admission. Within this subset of patients, in addition to variables assessed in the third step, three new variables related to the recent hospitalization episodes, i.e., primary diagnoses of fall injury, surgical interventions, and length of stay at hospital, were analyzed. The models for each variable were adjusted for the complete set of covariates determined at the second step.\u003c/p\u003e\u003cp\u003eFinally, to evaluate the discriminant ability of the identified risk factors for 30-day hospitalization, several combinations of significant variables were used for risk prediction (see supplementary material\u0026ndash;Table A5). Time-dependent concordance (c-index) and Brier scores were calculated for each model using 3-fold cross-validation. Additionally, the discriminant performance of the risk regression method used in this study [\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e] was compared with the widely used Fine-Gray method.\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003eThe study population had a median age of 81 years (interquartile range [IQR] 73\u0026ndash;87). The baseline characteristics of the study population are reported in Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e. The median time-to-hospitalization of the cohort was 7 months (IQR 1\u0026ndash;47). The median time-to-death was 24 months (IQR 4\u0026ndash;60). Almost 26% of the patients were hospitalized within 30 days, and roughly 8% of the patients died within the same 30-day window without being hospitalized. Figure\u0026nbsp;1 illustrates the CIFs of hospitalization and death over 180 days. Male sex, younger age groups, higher multimorbidity burden, and recent hospitalization demonstrated higher probabilities of hospitalization over time.\u003c/p\u003e\u003cp\u003e\u003cb\u003eFigure 1.\u003c/b\u003e Stratified cumulative incidence functions (95% CI band) of hospitalization and the competing outcome of death.\u003c/p\u003e\n\u003cp\u003e## insert Fig.\u0026nbsp;1 here ##\u003c/p\u003e\n\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eBaseline characteristics of study population in terms of hospitalization and death outcomes.\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"6\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u003cp\u003eMedian time-to-event, months (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c6\" namest=\"c5\"\u003e\u003cp\u003eCount (%) of 30-day outcomes\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eN (%)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003eHospitalization\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003eDeath\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003eHospitalization\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003eDeath\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFull cohort\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e11284 (100)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e7.0 (6.4\u0026ndash;7.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e23.8 (22.8\u0026ndash;24.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2941 (26.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e861 (7.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eStratified by:\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAge\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e18\u0026ndash;74\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3340 (29.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.3 (4.9\u0026ndash;6.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e43.5 (40.5\u0026ndash;47.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e954 (28.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e161 (4.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e75\u0026ndash;84\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3982 (35.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e6.6 (5.9\u0026ndash;7.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e25.4 (24.1\u0026ndash;27.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1079 (27.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e292 (7.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e85+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3962 (35.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e9.0 (8.0\u0026ndash;10.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e14.1 (13.0\u0026ndash;15.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e908 (22.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e408 (10.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSex\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFemale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e6076 (53.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e8.8 (8.1\u0026ndash;9.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e26.7 (25.5\u0026ndash;28.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1440 (23.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e453 (7.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e5208 (46.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.2 (4.8\u0026ndash;5.8 )\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e20.2 (18.2\u0026ndash;21.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1501 (28.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e408 (7.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMultimorbidity\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1566 (13.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e13.4 (11.0\u0026ndash;16.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e33.6 (29.8\u0026ndash;36.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e316 (20.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e80 (5.1)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1\u0026ndash;2\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e5215 (46.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e8.7 (8.1\u0026ndash;9.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e27.4 (25.5\u0026ndash;29.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1261 (24.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e387 (7.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e3+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4503 (39.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.1 (3.7\u0026ndash;4.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e16.7 (15.6\u0026ndash;18.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1364 (30.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e394 (8.7)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eRecent hospitalization\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2544 (22.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e9.8 (8.6\u0026ndash;11.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e20.7 (18.9\u0026ndash;22.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e553 (21.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e173 (6.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e8740 (77.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e6.2 (5.6\u0026ndash;6.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e24.8 (23.7\u0026ndash;25.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2388 (27.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e688 (7.9)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e5-year history of\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAlcohol misuse\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e832 (7.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.3 (4.1\u0026ndash;6.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e34.7 (30.2\u0026ndash;40.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e236 (28.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e40 (4.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAsthma\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e342 (3.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.8 (2.9\u0026ndash;7.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e27.7 (21.4\u0026ndash;36.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e102 (29.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e20 (5.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAtrial fibrillation\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2559 (22.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.3 ( 3.6\u0026ndash;5.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e14.5 (12.7\u0026ndash;16.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e757 (29.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e243 (9.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer, lymphoma\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e228 (2.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.7 (1.1\u0026ndash;2.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e7.0 (4.3\u0026ndash;9.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e95 (41.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e28 (12.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer, metastatic\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e483 (4.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.6 (3.1\u0026ndash;11.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.6 (1.4\u0026ndash;2.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e160 (33.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e125 (25.9)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer, non\u0026ndash;metastatic\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1316 (11.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.0 (3.7\u0026ndash;6.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e6.0 (4.7\u0026ndash;7.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e417 (31.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e205 (15.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic heart failure\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1189 (10.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e3.3 (2.7\u0026ndash;4.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e10.4 (8.4\u0026ndash;13.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e393 (33.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e133 (11.2)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic kidney disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1468 (13.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e3.2 (2.7\u0026ndash;3.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e14.1 (11.9\u0026ndash;16.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e485 (33.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e136 (9.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic pain\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2025 (17.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.8 (4.0\u0026ndash;5.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e27.7 (25.2\u0026ndash;30.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e562 (27.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e130 (6.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic pulmonary disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e15.79 (14.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e3.7 (3.1\u0026ndash;4.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e13.6 (12.2\u0026ndash;15.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e496 (31.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e149 (9.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCirrhosis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e219 (1.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.8 (1.1\u0026ndash;3.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e13.8 (9.2\u0026ndash;17.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e89 (40.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e14 (6.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eDementia\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1191 (10.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e13.8 (11.2\u0026ndash;16.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e21.8 (19.1\u0026ndash;24.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e225 (18.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e82 (6.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eDepression\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e601 (5.33)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.1 (4.1\u0026ndash;7.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e26.9 (23.2\u0026ndash;30.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e170 (28.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e43 (7.1)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eDiabetes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1850 (16.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e3.6 (3.1\u0026ndash;4.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e19.7 (17.3\u0026ndash;22.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e603 (32.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e127 (6.9)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eEpilepsy\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e383 (3.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.0 (3.0\u0026ndash;5.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e27.4 (21.1\u0026ndash;34.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e104 (27.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e21 (5.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHypertension\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4079 (36.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.3 (5.0\u0026ndash;6.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e22.7 (20.7\u0026ndash;24.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1120 (27.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e297 (7.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHypothyroidism\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e394 (3.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e6.0 (4.4\u0026ndash;8.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e20.5 (14.7\u0026ndash;26.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e103 (26.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e30 (7.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eInflammatory bowel disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e114 (1.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.8 (2.2\u0026ndash;11.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e28.8 (23.0\u0026ndash;47.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e37 (32.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e6 (5.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMultiple sclerosis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e92 (0.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.0 (2.7\u0026ndash;9.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e63.2 (51.4\u0026ndash;NR)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e26 (28.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;5\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMyocardial infarction\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e435 (3.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.4 (3.7\u0026ndash;7.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e18.9 (15.1\u0026ndash;25.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e121 (27.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e46 (10.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eParkinson\u0026rsquo;s disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e336 (3.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e5.1 (4.0\u0026ndash;7.1)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e25.5 (21.1\u0026ndash;30.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e88 (26.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e12 (3.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePeptic ulcer disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e138 (1.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e3.8 (2.4\u0026ndash;7.2)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e18.6 (10.1\u0026ndash;25.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e38 (27.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e12 (8.7)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePeripheral vascular disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1061 (9.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.2 (3.3\u0026ndash;5.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e16.1 (13.7\u0026ndash;18.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e334 (31.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e102 (9.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePsoriasis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e98 (0.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e6.0 (2.8\u0026ndash;13.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e32.5 (20.2\u0026ndash;46.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e23 (23.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e7 (7.1)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eRheumatoid arthritis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e395 (3.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e4.5 (3.0\u0026ndash;5.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e18.8 (13.6\u0026ndash;24.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e118 (29.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e34 (8.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSchizophrenia\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e75 (0.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e8.2 (3.8\u0026ndash;19.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e48.9 (28.0\u0026ndash;NR)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e14 (18.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;5\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eStroke or TIA\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2345 (20.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e6.6 (5.6\u0026ndash;7.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e28.1 (26.1\u0026ndash;30.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e571 (24.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e146 (6.2)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"6\" nameend=\"c6\" namest=\"c1\"\u003e\u003cp\u003eNR\u0026thinsp;=\u0026thinsp;upper confidence limit not reached; the 95% upper confidence band for the survival curve remained above 0.50 for the entire follow-up period.\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003cdiv id=\"Sec11\" class=\"Section2\"\u003e\u003ch2\u003eAge, sex, multimorbidity, and recent hospitalization (step 1)\u003c/h2\u003e\u003cp\u003eIn mutually adjusted models (Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e), each 10-year increase in age was associated with lower 30-day absolute risk (adjusted ARR [aARR] 0.96, 95% CI 0.93\u0026ndash;0.98). Male patients experienced a higher risk than females (aARR 1.16, 95% CI 1.09\u0026ndash;1.24). A clear dose-response with multimorbidity was evident: compared with patients without recorded morbidities, those with 1\u0026ndash;2 morbidities had 17% higher 30-day risk (aARR 1.17, 95% CI 1.04\u0026ndash;1.31), while patients with \u0026ge;\u0026thinsp;3 morbidities showed 43% increase (aARR 1.43, 95% CI 1.27\u0026ndash;1.61). A recent hospital stay (within seven days before the TS admission) remained an independent predictor, raising 30-day risk (aARR 1.24, 95% CI 1.14\u0026ndash;1.34). Longer-term 180-day associations were in the same direction as the 30-day risks, but the effect sizes were smaller in magnitude. Univariate estimates were directionally consistent but slightly larger in magnitude.\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eAnalysis of the association of age, sex, multimorbidity, and recent hospitalization with consequent hospitalization.\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"6\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e\u003cp\u003e30-day hospitalization\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c6\" namest=\"c5\"\u003e\u003cp\u003e180-day hospitalization\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eVariable in analysis\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003euARR\u003csup\u003e1\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003eaARR\u003csup\u003e2\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u003cp\u003euARR\u003csup\u003e1\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c6\"\u003e\u003cp\u003eaARR\u003csup\u003e2\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eAge\u003c/b\u003e\u003csup\u003e\u003cb\u003e*\u003c/b\u003e\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.94 (0.92\u0026ndash;0.97)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.96 (0.93\u0026ndash;0.98)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.95 (0.94\u0026ndash;0.97)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.96 (0.95\u0026ndash;0.98)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eSex\u003c/b\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFemale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.22 (1.14\u0026ndash;1.29)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.16 (1.09\u0026ndash;1.24)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.14 (1.1\u0026ndash;1.19)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.09 (1.05\u0026ndash;1.14)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eMorbidity Count\u003c/b\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1\u0026ndash;2\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.20 (1.07\u0026ndash;1.34)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.17 (1.04\u0026ndash;1.31)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.17 (1.09\u0026ndash;1.26)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.15 (1.07\u0026ndash;1.24)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e3+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.50 (1.34\u0026ndash;1.69)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.43 (1.27\u0026ndash;1.61)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.45 (1.34\u0026ndash;1.56)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.40 (1.30\u0026ndash;1.51)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eRecent Hospitalization\u003c/b\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003eReference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.26 (1.16\u0026ndash;1.36)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.24 (1.14\u0026ndash;1.34)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.14 (1.09\u0026ndash;1.20)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.13 (1.08\u0026ndash;1.19)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"6\" nameend=\"c6\" namest=\"c1\"\u003e\u003cp\u003e1. unadjusted ARR; 2. adjusted ARR by including all four covariates.; * per 10 unit increase in age\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eMorbidities (step 2)\u003c/b\u003eAs shown in Table\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e, after adjustment for the three core baseline covariates, the most substantial increases in both the 30-day and the 180-day absolute risks were seen for lymphoma, cirrhosis, and chronic kidney disease, followed by atrial fibrillation, chronic heart failure, chronic pulmonary disease, and diabetes. Notably, metastatic and non-metastatic cancers increased the 30-day risk, but their effect on longer-term risk did not reach statistical significance, highlighting a divergence between early readmission propensity and longer-term trajectories. Dementia and stroke/transient ischaemic attack were associated with significantly lower hospitalization risk across both time horizons. The 11 morbidities with significant 30-day ARR (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.05) were therefore carried forward as additional adjustment factors in subsequent analytic steps, together with the three core baseline covariates.\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eAssociation of selected morbidities with consequent hospitalization.\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"5\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e\u003cp\u003e30-day Hospitalization\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e\u003cp\u003e180-day Hospitalization\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eVariable in analysis\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eaARR\u003csup\u003eSAM\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003ep-value\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u003cp\u003eaARR\u003csup\u003eSAM\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u003cp\u003ep-value\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAlcohol misuse\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.93 (0.83\u0026ndash;1.05)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.25\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.93 (0.87\u0026ndash;1.00)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.05\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAsthma\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.04 (0.89\u0026ndash;1.22)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.61\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.98 (0.89\u0026ndash;1.08)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.65\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAtrial fibrillation*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.09 (1.01\u0026ndash;1.17)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.04\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.08 (1.03\u0026ndash;1.14)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer, lymphoma*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.48 (1.26\u0026ndash;1.74)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.25 (1.13\u0026ndash;1.38)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer, metastatic*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.16 (1.02\u0026ndash;1.33)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.03\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.94 (0.86\u0026ndash;1.04)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.24\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer, non-metastatic*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.15 (1.05\u0026ndash;1.25)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.99 (0.94\u0026ndash;1.06)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.95\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic heart failure*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.15 (1.05\u0026ndash;1.27)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.12 (1.05\u0026ndash;1.18)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic kidney disease*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.17 (1.07\u0026ndash;1.28)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.15 (1.09\u0026ndash;1.21)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic pain\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.99 (0.91\u0026ndash;1.07)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.76\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.04 (0.99\u0026ndash;1.09)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.07\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eChronic pulmonary disease*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.12 (1.02\u0026ndash;1.22)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.08 (1.02\u0026ndash;1.14)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCirrhosis*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.34 (1.13\u0026ndash;1.59)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.19 (1.07\u0026ndash;1.32)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eDementia*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.67 (0.59\u0026ndash;0.76)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.76 (0.71\u0026ndash;0.82)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eDepression\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.97 (0.85\u0026ndash;1.11)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.69\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.98 (0.91\u0026ndash;1.06)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.68\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eDiabetes*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.16 (1.06\u0026ndash;1.26)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.09 (1.03\u0026ndash;1.14)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eEpilepsy\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.90 (0.76\u0026ndash;1.07)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.25\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.05 (0.95\u0026ndash;1.15)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.35\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHypertension\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.95 (0.89\u0026ndash;1.03)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.22\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.99 (0.95\u0026ndash;1.04)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.74\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHypothyroidism\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.96 (0.81\u0026ndash;1.13)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.62\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.97 (0.88\u0026ndash;1.07)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.58\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eInflammatory bowel disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.10 (0.85\u0026ndash;1.44)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.46\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.94 (0.78\u0026ndash;1.12)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.48\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMultiple sclerosis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.02 (0.73\u0026ndash;1.41)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.92\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.04 (0.86\u0026ndash;1.25)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.71\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMyocardial infarction\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.95 (0.81\u0026ndash;1.11)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.96 (0.88\u0026ndash;1.06)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.44\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eParkinson\u0026rsquo;s disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.93 (0.77\u0026ndash;1.12)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.45\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.04 (0.94\u0026ndash;1.16)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.43\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePeptic ulcer disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.95 (0.72\u0026ndash;1.25)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.72\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.04 (0.89\u0026ndash;1.22)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.61\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePeripheral vascular disease\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.09 (0.99\u0026ndash;1.21)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.09\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.03 (0.97\u0026ndash;1.10)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.33\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePsoriasis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.77 (0.54\u0026ndash;1.10)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.16\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.89 (0.72\u0026ndash;1.09)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.27\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eRheumatoid arthritis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1.08 (0.92\u0026ndash;1.26)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.35\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.08 (0.99\u0026ndash;1.19)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.10\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSchizophrenia\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.64 (0.40\u0026ndash;1.02)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.06\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.83 (0.64\u0026ndash;1.06)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.14\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eStroke or TIA*\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e0.83 (0.76\u0026ndash;0.90)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.94 (0.89\u0026ndash;0.98)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e0.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"5\" nameend=\"c5\" namest=\"c1\"\u003e\u003cp\u003eaARR\u003csup\u003eSAM\u003c/sup\u003e = absolute risk ratio adjusted for sex, age, and multimorbidity\u003c/p\u003e\u003cp\u003e* Significant morbidities\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec12\" class=\"Section2\"\u003e\u003ch2\u003eHealthcare-utilization markers (step 3)\u003c/h2\u003e\u003cp\u003eAfter adjustment for core baseline and morbidity covariates, each of the three utilization indicators\u0026mdash;one-year history of hospitalization burden, polypharmacy, and frequency of surgery\u0026mdash;retained an independent association with subsequent hospitalization (Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e). Relative to patients with \u0026le;\u0026thinsp;1 inpatient hospital contacts, those with 2\u0026ndash;3 contacts exhibited 27% higher 30-day absolute risk (aARR 1.27, 1.13\u0026ndash;1.43), while those with \u0026ge;\u0026thinsp;4 contacts showed an increase of 58% (aARR 1.58, 1.41\u0026ndash;1.77). Medication count displayed a similar dose-response: compared with \u0026le;\u0026thinsp;4 unique drugs, prescriptions of 5\u0026ndash;9 and \u0026ge;\u0026thinsp;10 drugs were associated with 15% (aARR 1.15, 1.03\u0026ndash;1.27) and 28% (aARR 1.28, 1.16\u0026ndash;1.42) higher 30-day risks, respectively. Prior surgical activity also predicted hospitalization: one to two procedures conferred an aARR of 1.23 (1.13\u0026ndash;1.33), whereas three or more procedures increased the aARR to 1.34 (1.24\u0026ndash;1.44). All 180-day associations were smaller in magnitude, and in the case of polypharmacy, prescriptions of 5\u0026ndash;9 drugs did not increase the 180-day risk significantly compared with \u0026le;\u0026thinsp;4 drugs.\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eAssociation of healthcare-utilization indicators with subsequent hospitalization.\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"7\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u003cp\u003e30-day Hospitalization\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u003cp\u003e180-day Hospitalization\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eVariable in analysis\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCount (%)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003eaARR\u003csup\u003eSAMM\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u003cp\u003ep-value\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colname=\"c6\"\u003e\u003cp\u003eaARR\u003csup\u003eSAMM\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c7\"\u003e\u003cp\u003ep-value\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1-year history of\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHospitalizations\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u0026ndash;1\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1835 (16.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e2\u0026ndash;3\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3885 (34.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.27 (1.13\u0026ndash;1.43)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.10 (1.03\u0026ndash;1.18)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e4+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e5564 (49.3)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.58 (1.41\u0026ndash;1.77)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.29 (1.21\u0026ndash;1.38)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eUnique prescriptions\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u0026ndash;4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1919 (17.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e5\u0026ndash;9\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3877 (34.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.15 (1.03\u0026ndash;1.27)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.06 (0.99\u0026ndash;1.13)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.08\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e10+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e5488 (48.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.28 (1.16\u0026ndash;1.42)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.20 (1.13\u0026ndash;1.28)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSurgical procedures\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e6252 (55.4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1\u0026ndash;2\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2454 (21.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.23 (1.13\u0026ndash;1.33)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.10 (1.04\u0026ndash;1.15)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e3+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2578 (22.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.34 (1.24\u0026ndash;1.44)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.18 (1.13\u0026ndash;1.23)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"7\" nameend=\"c7\" namest=\"c1\"\u003e\u003cp\u003eaARR\u003csup\u003eSAMM\u003c/sup\u003e = absolute risk ratio adjusted for sex, age, multimorbidity, and significant morbidities.\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec13\" class=\"Section2\"\u003e\u003ch2\u003eCharacteristics of the recent hospitalization (step 4)\u003c/h2\u003e\u003cp\u003eAmong the 8740 patients whose index TS admission was preceded by a hospital discharge within seven days, the annual patterns of healthcare use remained influential. However, their impact differed across levels and between early and longer-term readmission horizons (Table\u0026nbsp;\u003cspan refid=\"Tab5\" class=\"InternalRef\"\u003e5\u003c/span\u003e). Three variables that characterized the recent hospital episode also proved informative. A primary diagnosis of fall injury was associated with lower 30-day risk (aARR 0.88, 0.80\u0026ndash;0.98) and also lower 180-day risk (aARR 0.92, 0.80\u0026ndash;0.98). If that recent stay involved a surgical intervention, 30-day risk increased (aARR 1.09, 1.01\u0026ndash;1.18), but the effect on 180-day risk was insignificant. Finally, length of hospital stay displayed a clear trend in the 30-day risk: 8\u0026ndash;14 days versus 1\u0026ndash;7 days yielded aARR 1.14 (1.05\u0026ndash;1.24) and stays exceeding 14 days elevated the risk by 31% (aARR 1.31, 1.19\u0026ndash;1.43). Regarding 180-day risk, only stays exceeding 14 days increased the risk (aARR 1.13, 1.07\u0026ndash;1.20).\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab5\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 5\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eAssociation of characteristics of recently-hospitalized patients with subsequent hospitalization (N\u0026thinsp;=\u0026thinsp;8740).\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"7\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u003cp\u003e30-day Hospitalization\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c7\" namest=\"c6\"\u003e\u003cp\u003e180-day Hospitalization\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eVariable in analysis\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCount (%)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003eaARR\u003csup\u003eSAMM\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u003cp\u003ep-value\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colname=\"c6\"\u003e\u003cp\u003eaARR\u003csup\u003eSAMM\u003c/sup\u003e (95% CI)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c7\"\u003e\u003cp\u003ep-value\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1-year history of\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHospitalizations\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u0026ndash;1\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e667 (7.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e2\u0026ndash;3\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3307 (37.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.14 (0.96\u0026ndash;1.35)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.14\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00 (0.91\u0026ndash;1.11)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.97\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e4+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4766 (54.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.41 (1.19\u0026ndash;1.68)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.17 (1.06\u0026ndash;1.29)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eUnique prescriptions\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u0026ndash;4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1531 (17.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e5\u0026ndash;9\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3038 (34.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.15 (1.02\u0026ndash;1.29)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.02\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.05 (0.98\u0026ndash;1.13)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.17\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e10+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4171 (47.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.33 (1.18\u0026ndash;1.49)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.21 (1.12\u0026ndash;1.30)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSurgical procedures\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e0\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4514 (51.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1\u0026ndash;2\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2063 (23.6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.18 (1.08\u0026ndash;1.28)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.05 (1.00\u0026ndash;1.11)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.05\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e3+\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2163 (24.7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.27 (1.16\u0026ndash;1.38)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.14 (1.08\u0026ndash;1.20)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eRecent hospitalization\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFall injury\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1752 (20.0)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e0.88 (0.80\u0026ndash;0.98)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.02\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.92 (0.87\u0026ndash;0.98)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSurgery\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2077 (23.8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.09 (1.01\u0026ndash;1.18)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.04\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.04 (0.97\u0026ndash;1.09)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.16\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eLength of stay\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e1\u0026ndash;7 days\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2756 (31.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003ereference\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026ndash;\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e8\u0026ndash;14 days\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3839 (43.9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.14 (1.05\u0026ndash;1.24)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.05 (1.00\u0026ndash;1.11)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.05\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u0026gt;\u0026thinsp;14 days\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2145 (24.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.31 (1.19\u0026ndash;1.43)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.13 (1.07\u0026ndash;1.20)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;0.0001\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"7\" nameend=\"c7\" namest=\"c1\"\u003e\u003cp\u003eaARR\u003csup\u003eSAMM\u003c/sup\u003e = absolute risk ratio adjusted for sex, age, multimorbidity, and significant morbidities.\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec14\" class=\"Section2\"\u003e\u003ch2\u003eDiscriminant ability of risk factors and models\u003c/h2\u003e\u003cp\u003eAmong several combinations of variables used to predict 30-day hospitalization risks in the complete cohort, the full model including sex, age, multimorbidity, recent hospitalization, significant morbidities, and healthcare-utilization markers performed best (see supplementary material\u0026ndash;Table A5) with a c-index of 0.6225 (95% CI 0.6108\u0026ndash;0.6342) and the Brier score being 0.1861 (95% CI 0.1822\u0026ndash;0.1899). In similar risk prediction tasks within the recently hospitalized patients, adding variables of the recent hospitalization episode, i.e., primary diagnosis of fall injury, surgery, and length of stay, did not significantly improve either the c-index (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.53) or the Brier score (\u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.12). The risk regression method used in this study outperformed the Fine-Gray method in most models, and a similar performance was observed in the baseline models including only sex, age, multimorbidity, or recent hospitalization (see supplementary material\u0026ndash;Table A6).\u003c/p\u003e\u003c/div\u003e"},{"header":"Discussion","content":"\u003cp\u003eWe examined risk factors for all-cause 30-day hospital (re)admissions among older patients entering Danish municipal TS facilities. Our study utilized a large cohort of TS patients from 14 municipalities distributed across four out of five regions of Denmark (see supplementary material\u0026ndash;Table A1). To our knowledge, this is the first systematic research on baseline risk factors of early hospitalization among Danish TS patients. Overall, our results demonstrated both concordance with and divergences from the existing literature, reflecting unique aspects of the Danish municipal TS and the differences in case-mix and care models worldwide.\u003c/p\u003e\u003cp\u003eWe found that having multiple chronic conditions was a key determinant of (re)hospitalization. This aligns with a broad literature identifying high comorbidity burdens as a major risk factor for post-acute readmissions [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e, \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e]. Similarly, our finding that higher levels of previous health care utilization, including polypharmacy, history of frequent hospitalizations and surgeries, having a recent hospitalization prior to TS admission, and prolonged previous hospital stay, increase the risk of return to acute care corroborates prior research in geriatric cohorts [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e, \u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e]. The overlap in risk profiles suggests that, regardless of setting, patients with complex medical needs and intense prior healthcare utilization are vulnerable to cycling back to the hospital.\u003c/p\u003e\u003cp\u003eOur results showed that male patients have a higher hospitalization risk as observed in several studies on geriatric rehabilitation units in Scotland and the United States [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e, \u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e, \u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e] and other geriatric cohorts [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e, \u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e]. However, there are other studies in the United States and Australia reporting no association between sex and hospitalization risk [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e]. Although there is no definitive explanation for the increased risk of hospitalization in men, some studies have hypothesized differences in health-seeking behaviors and adherence to treatment as a possible underlying factor [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e, \u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eOne notable divergence from some prior research was the role of age. We observed that increasing age was protective against hospitalization. Another study similarly reported a reduced readmission risk with older age in a rehabilitation setting [\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e], contrary to several other studies where advanced age either predicted higher readmissions [\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e, \u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e] or showed no significant association [\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e]. This discrepancy likely reflects selection and competing risk factors. The oldest frail patients in Denmark may be more often transitioned to long-term care or palliative pathways instead of hospital readmission, and some may have higher mortality, which we accounted for as a competing risk. As Fig.\u0026nbsp;1.b shows, older age groups have a higher probability of mortality without experiencing hospitalization over the 180-day follow-up.\u003c/p\u003e\u003cp\u003eOur analysis also highlighted specific chronic conditions associated with increased risk of 30-day hospitalization. We reported that chronic heart failure, atrial fibrillation, lymphoma, metastatic and non-metastatic cancer, chronic pulmonary disease, chronic kidney disease, cirrhosis, and diabetes are associated with increased risk of early hospitalization. These results are well-supported by prior research on both general and older adult populations [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e, \u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e, \u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e]. A notable observation was the insignificant association of metastatic and non-metastatic cancer with longer-term hospitalization risk. In our cohort, patients with metastatic and non-metastatic cancer had very short median survival times (1.6 months and 6 months, respectively). Thus, we speculate that such severe conditions might shift the outcome balance toward mortality or end-of-life care rather than repeat hospitalization. However, this does not explain the consistent increase in risk of 30-day and 180-day hospitalization in patients with lymphoma who also had a short median survival time (7 months). Interestingly, we observed that dementia, previous stroke, and recent fall injuries were associated with lower hospitalization risk, possibly due to selection. In a previous study, dementia and fall injuries were found to be protective against early mortality in TS patients, highlighting the possibility that these patients are admitted to TS for less critical needs [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eThe identified risk factors in our study point to both disease-specific and general care gaps that may inform interventions to preempt early rehospitalization among high-risk TS patients, though this is a challenging task. Previous research has shown that most interventions aimed at reducing hospital readmissions did not affect readmission rates [\u003cspan additionalcitationids=\"CR45\" citationid=\"CR44\" class=\"CitationRef\"\u003e44\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR46\" class=\"CitationRef\"\u003e46\u003c/span\u003e]. A systematic review on the impact of transitional care interventions on hospital readmission in older medical patients reported that most successful interventions were of high intensity, lasted at least one month, and specifically targeted patients at risk [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. Some disease-specific interventions have been successful in reducing early readmissions, e.g., for patients with heart failure [\u003cspan citationid=\"CR47\" class=\"CitationRef\"\u003e47\u003c/span\u003e], chronic pulmonary disease [\u003cspan citationid=\"CR48\" class=\"CitationRef\"\u003e48\u003c/span\u003e], or kidney disease [\u003cspan citationid=\"CR49\" class=\"CitationRef\"\u003e49\u003c/span\u003e]. However, evidence from a nationwide cohort study on older acutely admitted patients in Denmark revealed that roughly 73% of readmitted patients returned to hospital for a different reason than the previous diagnosis [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. Therefore, targeting a single disease may not be an effective approach on its own. Additionally, given the low specialization level of Danish TS facilities, implementing interventions for every disease-specific risk factor may not be practical. Meanwhile, holistic interventions could mitigate the cumulative risk from multimorbidity, and healthcare utilization factors. For instance, medication review and deprescribing have shown reductions in readmission rates among older adults [\u003cspan citationid=\"CR50\" class=\"CitationRef\"\u003e50\u003c/span\u003e], and multidisciplinary geriatric assessment teams in transitional care can reduce subsequent acute care use [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR51\" class=\"CitationRef\"\u003e51\u003c/span\u003e]. Notably, evidence from a single Danish TS facility shows that follow-up visits by an outgoing multidisciplinary geriatric team significantly reduced 30-day readmission [\u003cspan citationid=\"CR51\" class=\"CitationRef\"\u003e51\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eA major strength of our analysis was the use of competing risk framework. Given that the 30-day mortality rate in our population was not negligible when compared with the 30-day hospitalization rate (8% versus 26%), we employed competing risk models to account for the outcome of death preventing the occurrence of hospitalizations. Many studies omit competing risk analyses out of convenience or convention. However, violating the assumption of noninformative censoring, i.e., treating death as censoring, can lead to biased results by overestimating the risk of the main event of interest, especially in older, multimorbid populations [\u003cspan citationid=\"CR52\" class=\"CitationRef\"\u003e52\u003c/span\u003e, \u003cspan citationid=\"CR53\" class=\"CitationRef\"\u003e53\u003c/span\u003e]. A review of 100 studies published in prominent medical journals concluded that 46% were susceptible to competing risk bias [\u003cspan citationid=\"CR54\" class=\"CitationRef\"\u003e54\u003c/span\u003e], highlighting the importance of using competing risk models for accurate risk estimation. Furthermore, our use of additive competing risks regression modeling to directly estimate the absolute risk ratios improves the interpretability of results compared to other methods reporting associations on the hazard scale.\u003c/p\u003e\u003cp\u003eThe results of this study must be viewed in light of its limitations. Several important predictors identified in prior studies were not evaluated in our analysis due to data limitations. Functional ability, cognitive status, living alone, social support, and other socioeconomic factors were not captured, though evidence suggests each may affect patient outcomes [\u003cspan additionalcitationids=\"CR56 CR57\" citationid=\"CR55\" class=\"CitationRef\"\u003e55\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR58\" class=\"CitationRef\"\u003e58\u003c/span\u003e]. Also, the reasons for recent hospitalization (primary diagnoses) before TS admission were sparsely distributed as previously reported [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e], and therefore, we did not evaluate their potentially important role in readmissions. The only indicators we extracted from recent hospitalization episodes were primary diagnosis of fall injuries, surgical interventions, and length of stay at hospital. Furthermore, TS facility quality indicators were not investigated in this study. As a decentralized care setting, TS facilities vary in size, staffing mix, and the type of services they offer [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e] and there is evidence that patient characteristics and trajectories vary across municipalities [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. Another limitation of this study is the focus on all-cause hospitalizations without considering whether they were unplanned or preventable. All of these limitations are known to negatively affect the performance of most hospital readmission risk prediction models, resulting in relatively poor discriminant ability [\u003cspan citationid=\"CR59\" class=\"CitationRef\"\u003e59\u003c/span\u003e, \u003cspan citationid=\"CR60\" class=\"CitationRef\"\u003e60\u003c/span\u003e] as observed in our study. Finally, despite using a large cohort across multiple Danish municipalities and regions, our results may not be generalizable to other intermediate care settings due to the diverse and fragmented implementation of intermediate care globally [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e].\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eEarly (re)hospitalization after admission to Danish municipal temporary stay facilities was common (26.1% within 30 days) and occurred alongside substantial early mortality (7.6%), underscoring the need for robust transitional care in this setting. Risk was patterned by male sex, higher multimorbidity, recent hospitalization, and markers of intensive prior healthcare use (polypharmacy, repeated admissions, surgical procedures). In contrast, advancing age, dementia, and prior stroke/TIA were associated with lower risk. In recently hospitalized patients, a fall-injury index diagnosis lowered 30-day risk, while recent surgery and hospital stays\u0026thinsp;\u0026gt;\u0026thinsp;14 days increased it. Although discrimination was modest (c-index\u0026thinsp;~\u0026thinsp;0.62), the identified predictors can support risk stratification to prioritize higher-intensity transitional support (e.g., medication review/deprescribing, multidisciplinary geriatric outreach) for those most likely to return to hospital. Future research should integrate functional status, cognitive and social determinants, and TS facility characteristics, and distinguish unplanned or potentially preventable readmissions to sharpen prediction and guide targeted, scalable interventions in TS.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cdiv class=\"DefinitionList\"\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eTS\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eTemporary stay\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eCPR\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eCentral Person Register\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eICD\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eInternational classification of diseases\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eDNPR\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eDanish National Patient Registry\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eSKS\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eSundhedsv\u0026aelig;senets klassifikationssystem (Health care classification system)\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eATC\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eAnatomical therapeutic chemical classification\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eCIF\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eCumulative incidence function\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eCI\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eConfidence interval\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eARR\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eAbsolute risk ratio\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003euARR\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eUnadjusted absolute risk ratio\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eaARR\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eAdjusted absolute risk ratio\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eIFPW\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eInverse failure probability weighting\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eIQR\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eInterquartile range\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eTIA\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eTransient ischaemic attack\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors\u0026rsquo; contribution\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMR, KK, and KE conceptualized and designed the study. MR performed the statistical analysis and wrote the manuscript. MR and AP interpreted the results. KK, KE, and AP have read and commented on the manuscript. All authors have read and approved the final version of the manuscript for submission.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe study was funded by Novo Nordisk Foundation (grant number 0075454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and material\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDanish legislation does not allow individual-level data to be publicly available. Anonymized data can be accessed by authorized researchers after application to Forskeservice at the Danish Health Data Authority. MR had full access to the data. Coding scripts for the analysis are available upon request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthics approval and consent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis research project has been conducted in accordance with the principles of the Helsinki Declaration and further adheres to the legal requirements of the study country. This study was register-based, only anonymized data was used, data is presented in aggregate and anonymous form, and study participants were not contacted nor required any active participation. According to Danish law, approval from an ethics committee and informed consent to participate are not required for register-based studies (section 14.2 of the Act on Research Ethics Review of Health Research Projects and section 10 of the Data Protection Act). In terms of data protection, the study was registered at the University of Southern Denmark inventory (record no. 11.436).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no competing interests.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor details\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003csup\u003e1\u003c/sup\u003eDepartment of Engineering Technology and Didactics, Technical University of Denmark, Ballerup, Denmark. \u003csup\u003e2\u003c/sup\u003eDepartment of Public Health, University of Southern Denmark, Odense, Denmark. \u003csup\u003e3\u003c/sup\u003eHospital Pharmacy Funen, Odense University Hospital, Odense, Denmark.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eTakahashi PY, Leppin AL, Hanson GJ. Hospital to Community Transitions for Older Adults. Mayo Clin Proc. 2020;95:2253\u0026ndash;62. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.mayocp.2020.02.001\u003c/span\u003e\u003cspan address=\"10.1016/j.mayocp.2020.02.001\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLowthian J. How do we optimise care transition of frail older people? Age Ageing. 2016. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/ageing/afw171\u003c/span\u003e\u003cspan address=\"10.1093/ageing/afw171\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. :ageing;afw171v1.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eForster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ Can Med Assoc J J Assoc Medicale Can. 2004;170:345\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSezgin D, O\u0026rsquo;Caoimh R, O\u0026rsquo;Donovan MR, Salem MA, Kennelly S, Samaniego LL, et al. Defining the characteristics of intermediate care models including transitional care: an international Delphi study. Aging Clin Exp Res. 2020;32:2399\u0026ndash;410. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s40520-020-01579-z\u003c/span\u003e\u003cspan address=\"10.1007/s40520-020-01579-z\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSezgin D, O\u0026rsquo;Caoimh R, Liew A, O\u0026rsquo;Donovan MR, Illario M, Salem MA, et al. The effectiveness of intermediate care including transitional care interventions on function, healthcare utilisation and costs: a scoping review. Eur Geriatr Med. 2020;11:961\u0026ndash;74. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s41999-020-00365-4\u003c/span\u003e\u003cspan address=\"10.1007/s41999-020-00365-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eF\u0026oslash;nss Rasmussen L, Grode LB, Lange J, Barat I, Gregersen M. Impact of transitional care interventions on hospital readmissions in older medical patients: a systematic review. BMJ Open. 2021;11:e040057. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1136/bmjopen-2020-040057\u003c/span\u003e\u003cspan address=\"10.1136/bmjopen-2020-040057\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eHerfjord JK, Heggestad T, Ersland H, Ranhoff AH. Intermediate care in nursing home after hospital admission: a randomized controlled trial with one year follow-up. BMC Res Notes. 2014;7:889. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/1756-0500-7-889\u003c/span\u003e\u003cspan address=\"10.1186/1756-0500-7-889\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLiapi F, Chater AM, Kenny T, Anderson J, Randhawa G, Pappas Y. Evaluating step-down, intermediate care programme in Buckinghamshire, UK: a mixed methods study. BMC Public Health. 2023;23:1087. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12889-023-15868-5\u003c/span\u003e\u003cspan address=\"10.1186/s12889-023-15868-5\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMorando V, Holditch C, Inzitari M, Tozzi V, Hendry A. Understanding intermediate care development, supporting implementation and scaling up of intermediate care in Europe. Int J Integr Care. 2016;16:367. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.5334/ijic.2915\u003c/span\u003e\u003cspan address=\"10.5334/ijic.2915\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eThe Danish Organization of General Practitioners and Local Government Denmark. Definition af midlertidige d\u0026oslash;gnd\u0026aelig;kkede pladser [Definition of temporary 24-hour placements]. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://stps.dk/Media/638257904106148719/plo_og_kl_-_definition_af_midlertidige_d-gnd-kkede.pdf\u003c/span\u003e\u003cspan address=\"https://stps.dk/Media/638257904106148719/plo_og_kl_-_definition_af_midlertidige_d-gnd-kkede.pdf\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Accessed 31 July 2025.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKayser K, Christensen MR. Municipality of Copenhagen. Status vedr. midlertidige d\u0026oslash;gnophold [Status regarding temporary stays]. 2021. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.kk.dk/dagsordener-og-referater/Sundheds-%20og%20Omsorgsudvalget/m%C3%B8de-22062021/referat/punkt-3\u003c/span\u003e\u003cspan address=\"https://www.kk.dk/dagsordener-og-referater/Sundheds-%20og%20Omsorgsudvalget/m%C3%B8de-22062021/referat/punkt-3\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Accessed 31 July 2025.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eVinge S, Buch MS, Kjellberg PK. Det kommunale akutomr\u0026aring;de: Erfaringer og perspektiver p\u0026aring; udviklingen fra 15 kommuner [The municipal emergency area - Experiences and perspectives on the development from 15 municipalities]. The Danish Center for Social Science Research. 2021. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.vive.dk/media/pure/16209/5709970\u003c/span\u003e\u003cspan address=\"https://www.vive.dk/media/pure/16209/5709970\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Accessed 31 July 2025.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eHarbi H, Lundby C, Jensen PB, Larsen SP, R\u0026oslash;rb\u0026aelig;k LG, Ravn-Nielsen LV, et al. Characteristics and care trajectories of older patients in temporary stays in Denmark. Eur Geriatr Med. 2025. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s41999-025-01209-9\u003c/span\u003e\u003cspan address=\"10.1007/s41999-025-01209-9\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eHarbi H, Lundby C, Jensen PB, Larsen SP, R\u0026oslash;rb\u0026aelig;k LG, Ravn-Nielsen LV, et al. Medication use patterns among older patients in temporary stays in Denmark. Eur Geriatr Med. 2025. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s41999-025-01210-2\u003c/span\u003e\u003cspan address=\"10.1007/s41999-025-01210-2\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePugh J, Penney LS, No\u0026euml;l PH, Neller S, Mader M, Finley EP, et al. Evidence based processes to prevent readmissions: more is better, a ten-site observational study. BMC Health Serv Res. 2021;21. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12913-021-06193-x\u003c/span\u003e\u003cspan address=\"10.1186/s12913-021-06193-x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWeissman JS, Ayanian JZ, Chasan-Taber S, Sherwood MJ, Roth C, Epstein AM. Hospital Readmissions and Quality of Care. Med Care. 1999;37.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBalla U, Malnick S, Schattner A. Early Readmissions to the Department of Medicine as a Screening Tool for Monitoring Quality of Care Problems. Med (Baltim). 2008;87:294\u0026ndash;300. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1097/md.0b013e3181886f93\u003c/span\u003e\u003cspan address=\"10.1097/md.0b013e3181886f93\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCilla F, Sabione I, D\u0026rsquo;Amelio P. Risk Factors for Early Hospital Readmission in Geriatric Patients: A Systematic Review. Int J Environ Res Public Health. 2023;20:1674. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3390/ijerph20031674\u003c/span\u003e\u003cspan address=\"10.3390/ijerph20031674\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eGlans M, Kragh Ekstam A, Jakobsson U, Bondesson \u0026Aring;, Midl\u0026ouml;v P. Risk factors for hospital readmission in older adults within 30 days of discharge \u0026ndash; a comparative retrospective study. BMC Geriatr. 2020;20. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12877-020-01867-3\u003c/span\u003e\u003cspan address=\"10.1186/s12877-020-01867-3\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWillers C, Bostr\u0026ouml;m A-M, Carlsson L, Lager A, Lindqvist R, Rydwik E. Readmission within three months after inpatient geriatric care\u0026mdash;Incidence, diagnosis and associated factors in a Swedish cohort. PLoS ONE. 2021;16:e0248972. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1371/journal.pone.0248972\u003c/span\u003e\u003cspan address=\"10.1371/journal.pone.0248972\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKlinge M, Aasbrenn M, \u0026Ouml;zt\u0026uuml;rk B, Christiansen CF, Suetta C, Pressel E, et al. Readmission of older acutely admitted medical patients after short-term admissions in Denmark: a nationwide cohort study. BMC Geriatr. 2020;20. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12877-020-01599-4\u003c/span\u003e\u003cspan address=\"10.1186/s12877-020-01599-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eRasmussen MG, Ravn P, Molsted S, Tarnow L, Rosth\u0026oslash;j S. Readmission to hospital of medical patients \u0026ndash; A cohort study. Eur J Intern Med. 2017;46:19\u0026ndash;24. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.ejim.2017.07.008\u003c/span\u003e\u003cspan address=\"10.1016/j.ejim.2017.07.008\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eDombrowski W, Yoos JL, Neufeld R, Tarshish CY. Factors Predicting Rehospitalization of Elderly Patients in a Postacute Skilled Nursing Facility Rehabilitation Program. Arch Phys Med Rehabil. 2012;93:1808\u0026ndash;13. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.apmr.2012.04.018\u003c/span\u003e\u003cspan address=\"10.1016/j.apmr.2012.04.018\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBurke RE, Whitfield EA, Hittle D, Min S, Levy C, Prochazka AV, et al. Hospital Readmission From Post-Acute Care Facilities: Risk Factors, Timing, and Outcomes. J Am Med Dir Assoc. 2016;17:249\u0026ndash;55. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jamda.2015.11.005\u003c/span\u003e\u003cspan address=\"10.1016/j.jamda.2015.11.005\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eHughes LD, Witham MD. Causes and correlates of 30 day and 180 day readmission following discharge from a Medicine for the Elderly Rehabilitation unit. BMC Geriatr. 2018;18. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12877-018-0883-3\u003c/span\u003e\u003cspan address=\"10.1186/s12877-018-0883-3\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWan CS, Reijnierse EM, Maier AB. Risk Factors of Readmissions in Geriatric Rehabilitation Patients: RESORT. Arch Phys Med Rehabil. 2021;102:1524\u0026ndash;32. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.apmr.2021.01.082\u003c/span\u003e\u003cspan address=\"10.1016/j.apmr.2021.01.082\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eGriffin O, Li T, Beveridge A, N\u0026iacute; Chr\u0026oacute;in\u0026iacute;n D. Higher levels of multimorbidity are associated with increased risk of readmission for older people during post-acute transitional care. Eur Geriatr Med. 2023;14:575\u0026ndash;82. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s41999-023-00770-5\u003c/span\u003e\u003cspan address=\"10.1007/s41999-023-00770-5\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSchmidt M, Pedersen L, S\u0026oslash;rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u0026ndash;9. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s10654-014-9930-3\u003c/span\u003e\u003cspan address=\"10.1007/s10654-014-9930-3\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSchmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, S\u0026oslash;rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;449. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.2147/CLEP.S91125\u003c/span\u003e\u003cspan address=\"10.2147/CLEP.S91125\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eDanish Health Data Authority. Sundhedsv\u0026aelig;senets Klassifikationssystem [Health Care Classification System]. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://sundhedsdatastyrelsen.dk/indberetning/klassifikationer/sks-klassifikationer\u003c/span\u003e\u003cspan address=\"https://sundhedsdatastyrelsen.dk/indberetning/klassifikationer/sks-klassifikationer\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Accessed 30 July 2025.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eDanish Health Data Authority. SKS Browser. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://medinfo.dk/sks/brows.php\u003c/span\u003e\u003cspan address=\"https://medinfo.dk/sks/brows.php\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Accessed 30 July 2025.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePotteg\u0026aring;rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u0026oslash;rensen HT, Hallas J, Schmidt M. Data Resource Profile: The Danish National Prescription Registry. Int J Epidemiol. 2016;dyw213. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/ije/dyw213\u003c/span\u003e\u003cspan address=\"10.1093/ije/dyw213\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eAalen OO, Johansen S. An Empirical Transition Matrix for Non-Homogeneous Markov Chains Based on Censored Observations. Scand J Stat. 1978;5:141\u0026ndash;50.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eScheike TH, Zhang M-J. Lifetime Data Anal. 2008;14:464\u0026ndash;83. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s10985-008-9094-0\u003c/span\u003e\u003cspan address=\"10.1007/s10985-008-9094-0\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e. Flexible competing risks regression modeling and goodness-of-fit.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eRobins JM, Rotnitzky A, Zhao LP. Estimation of Regression Coefficients When Some Regressors are not Always Observed. J Am Stat Assoc. 1994;89:846\u0026ndash;66. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/01621459.1994.10476818\u003c/span\u003e\u003cspan address=\"10.1080/01621459.1994.10476818\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eFranchi C, Nobili A, Mari D, Tettamanti M, Djade CD, Pasina L, et al. Risk factors for hospital readmission of elderly patients. Eur J Intern Med. 2013;24:45\u0026ndash;51. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.ejim.2012.10.005\u003c/span\u003e\u003cspan address=\"10.1016/j.ejim.2012.10.005\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePrediction of potentially. avoidable readmission risk in a division of general internal medicine. Swiss Med Wkly. 2017;147. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.4414/smw.2017.14470\u003c/span\u003e\u003cspan address=\"10.4414/smw.2017.14470\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOttenbacher KJ, Karmarkar A, Graham JE, Kuo Y-F, Deutsch A, Reistetter TA, et al. Thirty-Day Hospital Readmission Following Discharge From Postacute Rehabilitation in Fee-for-Service Medicare Patients. JAMA. 2014;311:604. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1001/jama.2014.8\u003c/span\u003e\u003cspan address=\"10.1001/jama.2014.8\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eJencks SF, Williams MV, Coleman EA. Rehospitalizations among Patients in the Medicare Fee-for-Service Program. N Engl J Med. 2009;360:1418\u0026ndash;28. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1056/nejmsa0803563\u003c/span\u003e\u003cspan address=\"10.1056/nejmsa0803563\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSilverstein MD, Qin H, Mercer SQ, Fong J, Haydar Z. Risk Factors for 30-Day Hospital Readmission in Patients\u0026thinsp;\u0026ge;\u0026thinsp;65 Years of Age. Bayl Univ Med Cent Proc. 2008;21:363\u0026ndash;72. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/08998280.2008.11928429\u003c/span\u003e\u003cspan address=\"10.1080/08998280.2008.11928429\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWoz S, Mitchell S, Hesko C, Paasche-Orlow M, Greenwald J, Chetty VK, et al. Gender as risk factor for 30 days post-discharge hospital utilisation: a secondary data analysis. BMJ Open. 2012;2:e000428. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1136/bmjopen-2011-000428\u003c/span\u003e\u003cspan address=\"10.1136/bmjopen-2011-000428\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCimarolli VR, Falzarano F, Hicks S. Predictors of Rehospitalization in Post-Acute Rehabilitation among Different Ethnic Groups. J Am Med Dir Assoc. 2020;21:513\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jamda.2019.10.008\u003c/span\u003e\u003cspan address=\"10.1016/j.jamda.2019.10.008\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBogaisky M, Dezieck L. Early Hospital Readmission of Nursing Home Residents and Community-Dwelling Elderly Adults Discharged from the Geriatrics Service of an Urban Teaching Hospital: Patterns and Risk Factors. J Am Geriatr Soc. 2015;63:548\u0026ndash;52. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/jgs.13317\u003c/span\u003e\u003cspan address=\"10.1111/jgs.13317\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eHansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to Reduce 30-Day Rehospitalization: A Systematic Review. Ann Intern Med. 2011;155:520\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7326/0003-4819-155-8-201110180-00008\u003c/span\u003e\u003cspan address=\"10.7326/0003-4819-155-8-201110180-00008\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLinertov\u0026aacute; R, Garc\u0026iacute;a-P\u0026eacute;rez L, V\u0026aacute;zquez-D\u0026iacute;az JR, Lorenzo-Riera A, Sarr\u0026iacute;a-Santamera A. Interventions to reduce hospital readmissions in the elderly: in-hospital or home care. A systematic review: Prevention of readmissions in the elderly. J Eval Clin Pract. 2011;17:1167\u0026ndash;75. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/j.1365-2753.2010.01493.x\u003c/span\u003e\u003cspan address=\"10.1111/j.1365-2753.2010.01493.x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePannick S, Davis R, Ashrafian H, Byrne BE, Beveridge I, Athanasiou T, et al. Effects of Interdisciplinary Team Care Interventions on General Medical Wards: A Systematic Review. JAMA Intern Med. 2015;175:1288. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1001/jamainternmed.2015.2421\u003c/span\u003e\u003cspan address=\"10.1001/jamainternmed.2015.2421\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eAl Sattouf A, Farahat R, Khatri AA. Effectiveness of Transitional Care Interventions for Heart Failure Patients: A Systematic Review With Meta-Analysis. Cureus. 2022. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7759/cureus.29726\u003c/span\u003e\u003cspan address=\"10.7759/cureus.29726\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePress VG, Myers LC, Feemster LC. Preventing COPD Readmissions Under the Hospital Readmissions Reduction Program. Chest. 2021;159:996\u0026ndash;1006. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.chest.2020.10.008\u003c/span\u003e\u003cspan address=\"10.1016/j.chest.2020.10.008\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMathew AT, Strippoli GFM, Ruospo M, Fishbane S. Reducing hospital readmissions in patients with end-stage kidney disease. Kidney Int. 2015;88:1250\u0026ndash;60. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/ki.2015.307\u003c/span\u003e\u003cspan address=\"10.1038/ki.2015.307\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCarollo M, Crisafulli S, Vitturi G, Besco M, Hinek D, Sartorio A, et al. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis. J Am Geriatr Soc. 2024;72:3219\u0026ndash;38. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/jgs.19035\u003c/span\u003e\u003cspan address=\"10.1111/jgs.19035\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eThomsen K, Fournaise A, Matzen LE, Andersen-Ranberg K, Ryg J. Does geriatric follow-up visits reduce hospital readmission among older patients discharged to temporary care at a skilled nursing facility: a before-and-after cohort study. BMJ Open. 2021;11:e046698. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1136/bmjopen-2020-046698\u003c/span\u003e\u003cspan address=\"10.1136/bmjopen-2020-046698\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBerry SD, Ngo L, Samelson EJ, Kiel DP. Competing Risk of Death: An Important Consideration in Studies of Older Adults. J Am Geriatr Soc. 2010;58:783\u0026ndash;7. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/j.1532-5415.2010.02767.x\u003c/span\u003e\u003cspan address=\"10.1111/j.1532-5415.2010.02767.x\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSzychowski JM, Roth DL, Clay OJ, Mittelman MS. Patient death as a censoring event or competing risk event in models of nursing home placement. Stat Med. 2010;29:371\u0026ndash;81. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1002/sim.3797\u003c/span\u003e\u003cspan address=\"10.1002/sim.3797\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eVan Walraven C, McAlister FA. Competing risk bias was common in Kaplan\u0026ndash;Meier risk estimates published in prominent medical journals. J Clin Epidemiol. 2016;69:170\u0026ndash;e1738. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jclinepi.2015.07.006\u003c/span\u003e\u003cspan address=\"10.1016/j.jclinepi.2015.07.006\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eShih SL, Zafonte R, Bates DW, Gerrard P, Goldstein R, Mix J, et al. Functional Status Outperforms Comorbidities as a Predictor of 30-Day Acute Care Readmissions in the Inpatient Rehabilitation Population. J Am Med Dir Assoc. 2016;17:921\u0026ndash;6. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.jamda.2016.06.003\u003c/span\u003e\u003cspan address=\"10.1016/j.jamda.2016.06.003\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eAnderson RE, Birge SJ. Cognitive Dysfunction, Medication Management, and the Risk of Readmission in Hospital Inpatients. J Am Geriatr Soc. 2016;64:1464\u0026ndash;8. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/jgs.14200\u003c/span\u003e\u003cspan address=\"10.1111/jgs.14200\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBarrenetxea J, Tan KB, Tong R, Chua K, Feng Q, Koh W-P, et al. Emergency hospital admissions among older adults living alone in the community. BMC Health Serv Res. 2021;21:1192. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12913-021-07216-3\u003c/span\u003e\u003cspan address=\"10.1186/s12913-021-07216-3\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eJoynt Maddox KE, Reidhead M, Hu J, Kind AJH, Zaslavsky AM, Nagasako EM, et al. Adjusting for social risk factors impacts performance and penalties in the hospital readmissions reduction program. Health Serv Res. 2019;54:327\u0026ndash;36. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1111/1475-6773.13133\u003c/span\u003e\u003cspan address=\"10.1111/1475-6773.13133\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, et al. Risk Prediction Models for Hospital Readmission: A Systematic Review. JAMA. 2011;306:1688. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1001/jama.2011.1515\u003c/span\u003e\u003cspan address=\"10.1001/jama.2011.1515\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eZhou H, Della PR, Roberts P, Goh L, Dhaliwal SS. Utility of models to predict 28-day or 30-day unplanned hospital readmissions: an updated systematic review. BMJ Open. 2016;6:e011060. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1136/bmjopen-2016-011060\u003c/span\u003e\u003cspan address=\"10.1136/bmjopen-2016-011060\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"bmc-health-services-research","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bhsr","sideBox":"Learn more about [BMC Health Services Research](http://bmchealthservres.biomedcentral.com/)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/BHSR/default.aspx","title":"BMC Health Services Research","twitterHandle":"BMC_series","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"em","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Transitional care, Intermediate care, Post-acute care, Temporary stay, Older adults, Hospitalization, Hospital readmission, Risk regression, Competing risks, Denmark","lastPublishedDoi":"10.21203/rs.3.rs-7740773/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7740773/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground\u003c/h2\u003e\u003cp\u003eTransitions from hospital to community are high-risk for older adults. In Denmark, municipal temporary stay (TS) facilities provide short-term, bed-based post-acute support, but determinants of early (re)hospitalization after TS admission are not well described. We estimated baseline risk factors for 30-day and 180-day hospitalization among TS patients.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e\u003cp\u003eWe performed a register-based cohort study that includes adults with TS admission in 14 municipalities (2016\u0026ndash;2023). Individual-level linkages captured demographics, diagnosis history, healthcare-utilization markers, and characteristics of recent hospitalization episodes. Outcomes were all-cause hospitalization within 30 and 180 days after the index TS admission, with death treated as a competing event. We estimated cumulative incidence using the Aalen-Johansen method and fitted additive competing-risk regression with inverse failure probability weighting to obtain absolute risk ratios (ARRs). Discrimination for 30-day risk was assessed with time-dependent c-index and Brier score using 3-fold cross-validation.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e\u003cp\u003eAmong 11,284 patients (median age 81 years), 26.1% were hospitalized, and 7.6% died within 30 days without prior hospitalization. In adjusted models, male sex (ARR 1.16, 95% CI 1.09\u0026ndash;1.24), higher multimorbidity (1\u0026ndash;2 vs 0: 1.17, 1.04\u0026ndash;1.31; \u0026ge;3 vs 0: 1.43, 1.27\u0026ndash;1.61), and recent hospitalization (1.24, 1.14\u0026ndash;1.34) increased 30-day risk, whereas older age decreased it per 10 years (0.96, 0.93\u0026ndash;0.98). Several morbidities were associated with higher 30-day risk (cancer-related morbidities, cirrhosis, chronic kidney disease, chronic heart failure, atrial fibrillation, chronic pulmonary disease, diabetes), while dementia and prior stroke/TIA were associated with lower risk. Healthcare-utilization markers showed dose-response relations (\u0026ge;\u0026thinsp;4 prior hospitalizations: 1.58; \u0026ge;10 medications: 1.28; \u0026ge;3 procedures: 1.34). In the recently hospitalized subgroup, a fall-injury primary diagnosis reduced 30-day risk (0.88), recent surgery increased it (1.09), and hospital stays\u0026thinsp;\u0026gt;\u0026thinsp;14 days conferred higher risk (1.31). The best 30-day model yielded a c-index of 0.623 and Brier score of 0.186.\u003c/p\u003e\u003ch2\u003eConclusions\u003c/h2\u003e\u003cp\u003eEarly (re)hospitalization after TS admission is common and patterned by sex, multimorbidity, intensive prior healthcare use, and selected morbidities. Although model discrimination was modest, the identified risk factors can inform targeted interventions in transitional care delivered at TS settings.\u003c/p\u003e\u003ch2\u003eTrial registration\u003c/h2\u003e\u003cp\u003eClinical trial number: not applicable.\u003c/p\u003e","manuscriptTitle":"Baseline risk factors associated with all-cause early hospitalization of older patients following admission to Danish municipal temporary stays","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-10-23 16:08:45","doi":"10.21203/rs.3.rs-7740773/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-11-29T08:39:48+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-11-14T03:57:55+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-10-24T20:06:59+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"100168933517323816591429120330508925024","date":"2025-10-11T23:02:09+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"184697858918640133263855004623525583084","date":"2025-10-09T19:10:18+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-10-09T19:03:00+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2025-10-01T12:15:55+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-09-30T05:02:00+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-09-30T05:00:55+00:00","index":"","fulltext":""},{"type":"submitted","content":"BMC Health Services Research","date":"2025-09-29T09:58:53+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"bmc-health-services-research","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"bhsr","sideBox":"Learn more about [BMC Health Services Research](http://bmchealthservres.biomedcentral.com/)","snPcode":"","submissionUrl":"https://www.editorialmanager.com/BHSR/default.aspx","title":"BMC Health Services Research","twitterHandle":"BMC_series","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"em","reportingPortfolio":"BMC Series","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"b6da8899-3105-4051-8c18-f227b93d8828","owner":[],"postedDate":"October 23rd, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2026-01-19T16:46:57+00:00","versionOfRecord":{"articleIdentity":"rs-7740773","link":"https://doi.org/10.1186/s12913-026-14045-9","journal":{"identity":"bmc-health-services-research","isVorOnly":false,"title":"BMC Health Services Research"},"publishedOn":"2026-01-13 16:29:56","publishedOnDateReadable":"January 13th, 2026"},"versionCreatedAt":"2025-10-23 16:08:45","video":"","vorDoi":"10.1186/s12913-026-14045-9","vorDoiUrl":"https://doi.org/10.1186/s12913-026-14045-9","workflowStages":[]},"version":"v1","identity":"rs-7740773","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7740773","identity":"rs-7740773","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.